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ABSTRACT OF THE DISSERTATION
Co-registered Photoacoustic and Ultrasound Tomographic Imaging of Human Colorectal and
Ovarian Cancer: Light Delivery, System Development, and Clinical Study
by
Guang Yang
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2021
Professor Quing Zhu, Chair
Ovarian cancer remains the deadliest of all the gynecological malignancies. Conventional
screening tests, including pelvic examination, transvaginal ultrasound (TVUS), and blood testing
for cancer antigen 125 (CA-125), lack sufficient specificity for early ovarian cancer diagnosis.
Imaging modalities such as computed tomography (CT), positron emission tomography (PET),
and magnetic resonance imaging (MRI) have been used for surgical guidance. However, all of
these modalities have limitations in detecting small lesions.
Globally, colorectal cancer is the second most commonly diagnosed malignancy and the fourth
most common cause of cancer mortality. Accurate staging and post-treatment surveillance of this
prevalent disease are critical because treatment strategies are predicated upon the stage at
presentation and the patient’s response to pre-surgical therapy – in some instances, detailed
imaging allows certain patients to avoid surgery altogether. While colonoscopy and biopsy are the
gold-standard diagnostic tests for colorectal cancers, multiple imaging modalities are also utilized,
including optical imaging, endoscopic ultrasound (EUS), pelvic magnetic resonance imaging
(MRI), computed tomography (CT), and positron emission tomography (PET). Unfortunately,
each of these modalities has critical weakness in evaluating colorectal tumors. In staging colorectal

xv

tumors and evaluating their therapeutic response, more precise imaging modalities could transform
the standard of care.
This dissertation explores co-registered photoacoustic and ultrasound tomographic imaging of two
fatal cancers: ovarian cancer and colorectal cancer. It is composed of three main parts: light
delivery optimization/fiber optics, system development and optimization, and pilot patient and
sample study.
To begin, we designed, optimized, and evaluated an hand-held photoacoustic and ultrasound probe
suitable for endo-cavity subsurface tumor imaging. Compared to previous designs, the prototype
probe, consisting of four 1 mm multi-mode optical fibers attached to 1.5 mm diameter ball-shaped
fiber tips sandwiched between a transvaginal ultrasound transducer and a custom-made sheath,
demonstrated a higher light output and better beam homogeneity on the tissue subsurface.
Second, we developed a novel fiber diffuser tip using microspheres dispersed within an ultraviolet
(UV) adhesive to scatter light. This diffuser keeps the skin surface fluence under the maximum
permissible exposure (MPE), while enabling higher laser energy injection to enhance the
photoacoustic (PA) signal generated from the tissue.
Third, we proposed an improved beamformer, named lag-based delay multiply and sum combined
with coherence factor (DMAS-LAG-CF). Simulations and phantom experiments demonstrate that
compared with conventional delay and sum (DAS), the proposed algorithm can provide 1.39 times
better resolution and 10.77 dB higher contrast. For patient data, similar improvements in contrast
ratios have been observed. However, since diagnostic accuracy in distinguishing between cancer
and benign/normal groups is the significant measure, we have extracted the photoacoustic
histogram features of mean, kurtosis, and skewness. When mean and skewness are used as features,

xvi

DMAS-LAG-CF can improve cancer diagnosis, with an AUC of 0.91 in differentiating malignant
from benign ovarian lesions.
Fourth, to investigate the ability of co-registered photoacoustic and ultrasound tomographic
imaging to assess human colorectal cancer, we conducted a pilot study on 23 ex-vivo human
colorectal tissue samples that were collected immediately after surgical resection. Co-registered
photoacoustic images of malignancies showed significantly increased PAT signals compared to
normal regions of the same sample. We found statistically significant differences between
untreated colorectal tumors and normal tissues, based on the quantitative relative total hemoglobin
concentration (rHbT) computed from four optical wavelengths, spectral features such as the mean
spectral slope and 0.5 MHz intercept extracted from PAT and US spectral data, and image features
such as the first and second order statistics along with the standard deviation of the mean radon
transform of PAT images. Using either a logistic regression model or a support vector machine,
the best set of parameters of rHbT and PAT intercept achieved AUC values of 0.97 and 0.95 for
the training and testing data sets, respectively, in predicting histologically confirmed invasive
carcinoma. One limitation of the current system is its poor image resolution (~ 250 μm axial
resolution) limited by the commercial endo-cavity ultrasound transducer array (6 MHz central
frequency, 80% bandwidth). For better image resolution in high frequency PAT/US imaging, we
first decoded the pin configuration of a high-frequency transducer array (15 MHz central
frequency, 9-18 MHz bandwidth) and adapted it to our home-made 128 channel ultrasound pulsing
and receiving system (sampling rate: 40 MHz). To further improve the performance, we are
building a 64-channel FPGA-based high frequency photoacoustic imaging system with a sampling
rate of 80 MHz and signal-to-noise ratio (SNR) of 40 dB. For in-vivo patient study, this system
will be integrated with an endo-rectal probe with a side-firing fiber tip.
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Fifth, we investigated the laser safety of photoacoustic imaging, in preparation for its use in clinical
reproductive medicine. Using preimplantation mouse blastocyst stage embryos, we assessed
potential DNA damage from photoacoustic laser exposure. Different embryo groups were exposed
to either 5- or 10- minute 15-Hz laser doses (typical clinical doses), or a 1-minute 1-kHz laser dose
(a significantly higher dose). We demonstrated that typical lasers and exposure times used for
photoacoustic imaging do not induce increased cell death in mouse blastocysts.
Sixth, we demonstrated a novel fiber endface photoacoustic generator using IR 144 laser dye dispersed
within an ultraviolet (UV) adhesive. The generator provides wide acoustic bandwidth in the transducer
frequency range of 2-7 MHz, high thermal conversion efficiency (> 90%), good PA intensity controllability
(via the easily controlled IR 144 concentration), and high feasibility (simple procedures). Through a series
of experimental validations, we show this fiber-based endface photoacoustic generator can be a useful tool
for a broad range of biomedical applications, such as calibrating the local absorption coefficient of
biological tissue for quantitative photoacoustic tomography.
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Chapter 1: Introduction
Ovarian cancer remains the deadliest of all the gynecological malignancies. According to the
American Cancer Society, 21,750 women in the United States were diagnosed with ovarian cancer
in 2020, and 13,940 deaths were reported [1]. Colorectal cancer is the second most common
malignancy diagnosed globally and the fourth leading cause of cancer mortality, with more than
100,000 new cases diagnosed annually in the US [1-2]. Photoacoustic imaging (PAI), also known
as optoacoustic imaging (OA), is an emerging biomedical imaging modality that uses the
resolution of ultrasound imaging and the contrast of optical imaging to provide structural and
functional information [3-4]. Optical absorption, the main PA contrast, is directly related to tumor
angiogenesis and tumor hypoxia. Tumor angiogenesis and oxygen consumption are significant
indicators for tumor growth, metastasis, and therapeutic response [5-6]. PAI has demonstrated its
potential for image-guided diagnosis in oncology (e.g., breast [7-9], thyroid [10-11], cervical [12],
colorectal [13], ovarian [14-17], and prostate cancers [18-19]), peripheral vascular diseases
(PVDs) [20], joint inflammations [21-23], and skin diseases [24-26]. Our lab focuses on
assessment of human ovarian cancer and colorectal cancer using co-registered multispectral
photoacoustic and ultrasound tomographic imaging. Because two or more optical wavelengths are
used, photoacoustic waves can be used to reconstruct the distribution of oxygenated and
deoxygenated hemoglobin, which are the main chromophores related to tumor angiogenesis and
hypoxia. Oxygen saturation (sO2) can then be measured, which is an important indicator of tumor
metabolism and therapeutic response [14].
This thesis begins by introducing facts about and known causes of ovarian cancer, colorectal
cancer, and surface tumors, then it describes conventional screening, staging, and treatment
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response monitoring methods. It also discusses the principles of PAI and its clinical applications
especially in oncology. Finally, we introduce the progress of our lab’s work on co-registered
photoacoustic and ultrasound tomographic (PAT/US) imaging.
In Chapter Two, we report the optimal design, implementation, and evaluation of an optical fiberbased transvaginal PAT/US imaging probe for endo-cavity imaging of adenocarcinomas.
In Chapter Three, we develop an effective fiber diffuser tip to reduce the fluence on the target
tissue surface while injecting more laser energy and enhancing the photoacoustic signal generated
from the tissue.
In Chapter Four, we propose an improved beamformer, named lag-based delay multiply and sum
combined with coherence factor (DMAS-LAG-CF), to improve spatial resolution and image
contrast for better in vivo ovarian cancer diagnosis.
In Chapter Five, to investigate the ability of co-registered PAT/US imaging to assess human
colorectal cancer, we describe a pilot study on 23 ex-vivo human colorectal tissue samples
collected immediately after surgical resection. To improve the spatial resolution of the current
system, we have built a 64-channel FPGA based high frequency photoacoustic imaging system
with a sampling rate of 80 MHz and signal-to-noise ratio (SNR) of 40 dB. For in-vivo patient study,
we have integrated this system with a commercial endo-rectal probe with a side-firing fiber tip.
In Chapter Six, we investigate the laser safety of photoacoustic imaging, with an eye to its adoption
by clinical reproductive medicine: using preimplantation mouse blastocyst stage embryos, we
examine potential DNA damage from photoacoustic laser exposure.
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In Chapter Seven, we develope a novel fiber endface photoacoustic generator that provides wide
acoustic bandwidth, high thermal conversion efficiency, good PA intensity controllability, and
high feasibility.
In Chapter Eight, we summarize the dissertation and present possible directions for future work in
transmission-mode ultrasound imaging using the fiber endface photoacoustic generator. We also
propose using photoacoustic remote-sensing imaging to evaluate human ovarian cancer and
colorectal cancer.

1.1 Cancer
1.1.1 Ovarian Cancer
Ranking fifth among fatal cancers affecting women, ovarian cancer accounts for more deaths than
any other cancer of the female reproductive system. According to the American Cancer Society,
in 2020, about 21,750 women received a new diagnosis of ovarian cancer and about 13,940 women
died from ovarian cancer. Due to the lack of early screening and diagnostic techniques, many
women are diagnosed with ovarian cancer when it is already at stages III or IV, where the mortality
rates are high (70 to 75%). Conventional screening tests, including pelvic examination,
transvaginal ultrasound (TVUS), and blood testing for cancer antigen 125 (CA-125), lack
sufficient specificity for early ovarian cancer diagnosis. Imaging modalities such as computed
tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI)
have been used for surgical guidance. However, all of these modalities have limitations in
detecting small lesions. In previous work, to address this limitation, we developed a co-registered
photoacoustic and TVUS technique to improve ovarian cancer diagnosis.
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1.1.2 Colorectal Cancer
Adenocarcinoma of the colon and rectum is the second most common malignancy diagnosed
globally and the 4th leading cause of cancer mortality. Accurate staging and post-treatment
surveillance of this prevalent disease are critical because treatment strategies are predicated upon
the stage at presentation and the response to pre-surgical therapy—in some instances, detailed
imaging allows certain patients to avoid surgery altogether. Colonoscopy and biopsy are the goldstandard diagnostic

tests

for colorectal

cancers. They work

reasonably well

for

diagnosis/screening, but are not used for staging and monitoring treatment response. Endoscopic
ultrasound (EUS) and magnetic resonance imaging (MRI) are good for staging, but not used for
monitoring treatment response. Also, MRI is costly. Computed tomography (CT) and positron
emission tomography (PET) are not used much: they suffer from low specificity and sensitivity,
and they require radiation. New imaging modalities to stage cancer’s invasion and predict the
patient’s therapeutic response could greatly improve patient outcomes.

1.1.3 Surface Tumor
Adenocarcinoma is a type of cancerous tissue that forms in mucus-secreting glands throughout the
body. For example, adenocarcinomas make up around 96% of colorectal cancers, and some
cervical cancers (10%) are also adenocarcinomas. The depth of invasion for early stage
adenocarcinoma is generally between 1 mm to 7 mm. For example, the stromal invasion depth for
cervical adenocarcinoma has been measured by microscopy to be 5 mm or less from the base of
the epithelium, with a horizontal spread of 7 mm or less. Previously, our group designed several
optical fiber-based transvaginal PAT/US imaging probes for ovarian cancer diagnosis. In the
design presented here, the 8 to 10 mm thick vaginal muscle wall functions as the light diffuser to
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homogenize the light beam before it reaches the ovary. However, the light beam is not optimized
for endo-cavity imaging of surface tumors, such as adenocarcinomas.

1.2 Photoacoustic Imaging
1.2.1 The Principles of Photoacoustic Imaging
PAI works on the basic principle of the PA effect, where usually a light beam (usually from a laser)
with a short pulse width (pulse duration < 10 ns) illuminates the target tissue. For efficient
generation of PA waves, the pulse duration of the laser should be within the thermal relaxation
time and stress relaxation time, i.e., the excitation is in thermal and stress confinement. Upon laser
irradiation, chromophores in the tissue (such as blood, melanin, lipid, and water) absorb the light
and convert it into heat, generating a local temperature rise. This temperature rise creates a
thermos-elastic expansion (the so-called initial pressure rise) that generates an acoustic wave. The
propagation of successive acoustic waves is finally detected by ultrasonic transducers. Because
sound scatters 1000 times less than light in tissue, the acoustic signal propagates much farther in
biological tissue without significant attenuation. The absorber size and the pulse width of the laser
excitation dictate the bandwidth of the generated acoustic wave (ranging from several tens of hertz
to hundreds of megahertz).
Because each tissue chromophore exhibits its own characteristic absorption spectrum, conducting
PAI at multiple wavelengths allows their relative quantification and helps to investigate
physiological changes in disorders. This information can reveal the mechanism behind the
disorders and suggest how they can be managed effectively.
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Generally, PAT systems can be grouped into two configurations subjected to their combination of
optical illumination methods and acoustic detection methods: photoacoustic microscopy (PAM)
which is based on mechanical scanning of a focused or diffused excitation light beam and a focused
single element ultrasonic transducer (Figure 1.1 (a)-(c)) and photoacoustic computed tomography
(PACT) which is inverse reconstruction image formation, based on widefield light illumination
and acoustic detection at multiple locations (Figure 1.1 (d)-(g)). PAI can also be implemented for
endoscopy (Figure 1.1 (h)). Furthermore, because it combines optical excitation with acoustic
detection, PAI is compatible with complementary imaging modalities, especially the following coregistered photoacoustic and ultrasound tomographic imaging in chapter 1.3.
PAM can be further classified into optical-resolution PAM (OR-PAM) (Figure 1.1 (a) and (b)) and
acoustic-resolution PAM (AR-PAM) (Figure 1.1 (c)) depending on usage of ultrasound focusing,
or light focusing, or both to achieve improved spatial resolution images. In both OR-PAM and
AR-PAM, the axial resolution is determined acoustically. In OR-PAM, the optically determined
lateral resolution is typically finer than the axial resolution. Conversely, in AR-PAM, the axial
resolution is typically finer than the lateral resolution.
PACT can be configured with a 1D ultrasonic transducer array (Figure 1.1 (d) and (e)), a 2D
transducer array (Figure 1.1 (f)), or their scanning equivalents (Figure 1.1 (g)).
The imaging depth of PAI scales over a wide range from the quasi-ballistic regime (typically ≤ 1
mm in tissue) to the diffuse regime (typically ≥ 10 mm in tissue), up to the dissipation limit (~ 10
cm in tissue). Reducing the imaging depth of PAI improves its spatial resolution in approximate
proportion. As a rule of thumb, the ratio of the imaging depth to the resolution is ~ 200, permitting
PAI to provide high-resolution imaging across a wide range of imaging depths (Figure 1.2).
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Figure 1.1: Schematic of major embodiments of photoacoustic imaging (from Ref. [4]). (a)
Transmission-mode OR-PAM system, where the ultrasonic transducer (UT) and the waterimmersion focusing lens are on opposite sides of the object. (b) Reflection-mode OR-PAM system
with an optical-acoustic combiner that transmits light but reflect sound. (c) AR-PAM system with
a dark-field illumination. The laser light is only weakly focused, with the UT in the dark cone. (d)
PACT system with a ring-shaped ultrasonic transducer array (UTA). The laser beam is expanded
and homogenized by a diffuser to provide widefield illumination. (e) PACT system with a linear
UTA. The excitation light is delivered through a fused-end, bifurcated fiber bundle that flanks both
sides of the UTA. (f) PACT system with a hemispherically shaped UTA. The UTA is rotated
around the object to be imaged to provide dense spatial sampling for 3D imaging. (g) PACT system
7

with a 2D Fabry-Perot interferometer as the acoustic sensor. The PA waves are recorded by raster
scanning a probing laser beam over the surface of the interferometer. (h) Side-viewing
intravascular PA catheter with an outer diameter of 1.25 mm, including the protective sheath in
which the catheter rotates.
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Figure 1.2: Photon propagation regimes in soft tissue and the penetration limits of representative
high-resolution optical imaging modalities (from Ref. [4]). (a) Photon propagation regimes in soft
tissue and association with the penetration limits of high-resolution optical imaging modalities.
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The four regimes are divided at photon propagation depths of approximately 0.1 mm (aberration
limit), 1 mm (diffusion limit), 10 cm (dissipation limit), and 1 m (absorption limit), with an optical
absorption coefficient of 0.1 cm-1, optical scattering coefficient of 100 cm-1 and anisotropy of 0.9.
The classification holds in the optical-scattering-dominant media. Note that the penetration limits
shown here are order-of-magnitude approximations and the penetration of wavefront engineering
is a theoretical projection. (b) Single generation and detection in confocal microscopy (CFM), twophoton microscopy (TPM) and PAT, with different penetration limits in scattering tissue. The
colors shown for the excitation light do not represent the true optical wavelengths.

1.2.2 The Clinical Applications of PAT
Breast Imaging
Photoacoustic imaging of the breast has garnered immense interest among researchers worldwide
owing to the penetration depth it can comfortably achieve to over the entire, if not most of the
breasts. Breast cancer is the most common cancer in women and a leading cause of cancer-related
death worldwide. Oraevsky et al. demonstrated the first use of PAI for breast imaging in patients
as early as 2001 [31]. Then Manohar et al. applied the Twente Photoacoustic Mammoscope to
human breast imaging and near-infrared photoacoustic images of regions-of-interest in 4 of the 5
cases of patients with symptomatic breast reveal higher intensity which is attributed to vascular
distribution associated with cancer [32]. Ermilov et al. designed, fabricated, and tested the laser
optoacoustic imaging system for breast cancer detection (LOIS-64). They used LOIS-64 to
perform a preliminary clinical studies on 27 patients [33]. Kruger et al. developed a dedicated
breast photoacoustic mammography system using a spherical detector aperture of 512 elements
[34]. They imaged four human volunteers and the vasculature was well visualized throughout the
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breast tissue, including to the chest wall. Kitai et al. developed a photoacoustic system wherein the
patients again lie in a prone position with the breast suspended and compressed between two plates
and illuminated through both plates [35]. Since multiple wavelengths were used, they calculated
sO2 from 26 patients, and all detected lesions showed lower sO2 levels as compared to the
surrounding and contralateral breast tissues. Diot et al. introduced fast handheld multispectral
optoacoustic tomography (MSOT) of the breast at 28 wavelengths, aiming to identify highresolution optoacoustic patterns of breast cancer and noncancerous breast tissue [36]. Very
recently, two high impact system and clinical trials have been developed and performed for breast
cancer imaging [37, 7-9]. Neuschler et al. completed a large multicenter prospective clinical trial
of over 2000 women, using the photoacoustic imaging system developed by Seno Medical
Instruments. The combination of PAT and US exceeded US specificity by 14.9% with similar
sensitivity (US: 96% vs. 98.6%) [37]. Lin et al. developed a single-breath-hold photoacoustic
computed tomography (SBH-PACT) system to reveal detailed angiographic structures in human
breasts as shown in Figure 1.3 [8]. SBH-PACT features a deep penetration depth (4 cm in vivo)
with high spatial and temporal resolutions (255 μm in plane resolution and a 10 Hz 2D frame rate).
By scanning the entire breast within a single breath hold (~ 15 s), a volumetric image can be
acquired and subsequently reconstructed. They also demonstrated multipurpose imaging to reveal
detailed angiographic information in biological tissues ranging from the rodent brain to the human
breast [9].
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Figure 1.3: Representations of the SBH-PACT system and healthy breast imaging (from Ref. [8]).
a Perspective cut-away view of the system with data acquisition components removed. b
Perspective view of the system with patient bed and optical components removed. c Vasculature
in the right breast of a 27-year-old healthy female volunteer with color-encoded depths.
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Brain Imaging
Clinical brain imaging is one of the most challenging applications for photoacoustic imaging, due
to strong optical scattering by the skull and brain tissue, which severely limits the optical fluence.
Furthermore, the acoustic signal became distorted and attenuated on transit from the brain back
through the skull and scalp. Multiple studies have performed photoacoustic brain imaging in small
animals in vivo using PAT. Wang et al. firstly reported in vivo noninvasive transdermal and
transcranial imaging of the structure and function of rat brain by means of laser-induced
photoacoustic tomography (PAT) [38]. Nasiriavanaki et al. developed a functional connectivity
photoacoustic tomography system, which allows noninvasive imaging of resting-state functional
connectivity in the mouse brain, with a large field of view and a high spatial resolution [39]. Laufer
et al. applied a Fabry-Perot polymer film sensing interferometer to image the mouse brain [40].
Noninvasive images of the vasculature in the mouse brain were obtained at different wavelengths
between 590 and 889 nm, showing that the cerebral vascular anatomy can be visualized with high
contrast and spatial resolution to depths up to 3.7 mm. Zhang et al. reported a PACT system
equipped with a high frequency linear transducer array for mapping the microvascular network of
a whole mouse brain with the skull intact and studying its hemodynamic activities [41]. Gottschalk
et al. demonstrated both ex vivo and non-invasive in vivo functional optoacoustic (OA)
neuroimaging of mice expressing the genetically encoded calcium indicator GCaMP6f [42] as
shown in Figure 1.4. The approach offers rapid, high-resolution three-dimensional snapshots of
whole-brain neuronal activity maps using single OA excitations. Very recently, a few studies have
addressed its feasibility on human brain imaging [27, 43]. Wang et al. conducted experiments to
examine the feasibility of functional imaging of neonatal brains in a noninvasive transcranial
manner by using reflection mode photoacoustic technique for the first time [43]. Nie et al.
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demonstrated the feasibility of PAT through a whole adult human skull for the first time by using
a photon recycler to increase light transmittance through the skull [27].

Figure 1.4: Bi-modal OA and fluorescence imaging of isolated brains (from Ref. [42]). a, 3D
rendering the imaging setup featuring a 512-element spherical matrix transducer array inserted
into a custom-made 3D-printed holder. The holder features an inlet and outlet to facilitate perfusion
with ACSF while the excised brain in placed on top of a transparent polyethylene foil that is
attached to the submerged sample mount. The brain is evenly illuminated via seven light guides
(fibers) and a sensitive scientific complementary metal-oxide semiconductor camera is positioned
at the top for concurrent wide-field fluorescence imaging. b, Distribution of detection elements on
the spherical array, with its effective volumetric imaging FOV indicated by the red bounding box.
c, Representative volumetric OA data recorded from an excised GCaMP6f-expressing brain at an
excitation wavelength of 488 nm. d, Corresponding planar fluorescence image. The glass capillary
visible on top of the right cortex (RC) was used for intracortical injections. e, Maximum intensity
projections (axial, top; sagittal, middle; and coronal, bottom) of the 3D OA dataset shown in c. f,
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Representative coronal (top), sagittal (middle) and transverse orthoslices (bottom) of the 3D OA
image acquired at 590 nm.

Gastrointestinal Imaging
Under acute conditions of the clinical phenotypes of inflammatory bowel diseases i.e. Crohn’s
disease (CD) and ulcerative colitis, the care management entails constant adjustment of therapeutic
interventions to avoid severe irreversible complications. As shown in Figure 1.5, Knieling et al.
conducted a pioneering study involving 108 patients with varying degrees of CD severity [28].
They used a clinical MSOT Acuity system fitted with a handheld detector (3 – 4 MHz, 256
transducer elements) to acquire images from abdomen and monitor the changes in colon upon
inflammation. This study demonstrated a major distinction in single wavelength data at 760 nm
and HbT signals between patients who show no inflammation in the intestines via scope and those
with low grade inflammation. Future more, Waldner et al. show a continuous increase of total and
HbO2 content and sO2 in the intestinal wall correlating with endoscopic and microscopic intestinal
inflammation [44]. Thus, multispectral optoacoustic tomography seems a promising approach to
quickly and noninvasively evaluate disease activity in CD patients and might therefore serve as a
tool to more rapidly adapt therapy regimes to personal needs.
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Figure 1.5: MSOT imaging for the assessment of Crohn’s Disease activity (from Ref. [28]). A, the
transabdominal imaging approach, which uses the same detector for laser light emission and
ultrasonic detection of signal levels by means of MSOT. B, MSOT-derived total Hb signal levels
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in the intestinal wall (in both the large bowel and the small intestine) in 44 patients with Crohn’s
disease with different degrees of endoscopic inflammation. C, representative images of MSOT
measurements of total Hb in the large bowel and small intestine in patients with different grades
of endoscopic disease activity.

Gynecological and Urologic Imaging
Both the male and female reproductive and urological systems present attractive clinical
opportunities for PAT since the illumination and acoustic detection can be positioned in relative
proximity to the target organ by using an endocavity device, such as in the prostate imaging. Wang
et al. demonstrated the feasibility of photoacoustic tomography (PAT) for noninvasive imaging of
prostate cancer through the study on a canine model in vivo [45]. Yassen et al. developed a laser
OA imaging system for the prostate [46]. The system consists of a fiber-coupled Q-switched laser
operating at 757 nm, a commercial 128-channel ultrasonic probe, a digital signal processor, and
software that uses the filtered radial back-projection algorithm for image reconstruction. The
system is used to reconstruct OA images of a blood-rich lesion induced in vivo in a canine prostate.
Kumon et al. performed a frequency-domain analysis of the radio-frequency signals from
photoacoustic imaging to generate quantitative parameters for classification of representing
prostate adenocarcinoma tumors and adjacent normal flank tissue in a murine model [47]. Dogra
et al. validated that ex-vivo multispectral photoacoustic imaging can differentiate between
malignant prostate tissue, benign prostatic hyperplasia, and normal prostate tissue involving a total
of 30 patients undergoing prostatectomy for biopsy-confirmed prostate cancer [19]. Horiguchi et
al. developed the first combined ultrasonic/ photoacoustic device for clinical use and tested it in a
pilot study on seven patients to improve real-time visualization of the neurovascular bundle during
radical prostatectomy [48]. Very recently, Kothapalli et al. reported the development and bench17

to-bedside translation of an integrated TURS and photoacoustic (TRUSPA) device as shown in
Figure 1.6 [29]. TRUSPA uses a miniaturized capacitive micro-machined ultrasonic transducer
array for simultaneous imaging of anatomical and molecular optical contrasts [intrinsic:
hemoglobin; extrinsic: intravenous indocyanine green (ICG)] of the human prostate. In conclusion,
TRUSPA has high potential to differentiate clinically relevant and insignificant PCa cancers,
replace/reduce random biopsies with targeted biopsies, and help select suitable treatment options.

Figure 1.6: Schematics and photographs of TRUSPA imaging of the human prostate (from Ref.
[29]). (A) Schematic representation of transrectal imaging of prostate (P) using the TRUSPA
device. (B) Schematics of the distal end of the TRUSPA device and its cross section showing key
components. (C) Photograph of the TRUSPA device with a 23-mm scale bar. (D) Magnified
photograph showing the distal end of the device that is inserted into the rectum of the patient. The
three dark lines around three sides of the device are the output end of the optical fibers that deliver
18

light into the prostate from three different planes [the red colored planes shown in (B)]. The device
is encapsulated with a gray-color PDMS lens (yellow-dotted rectangular box) above the CMUT
surface to achieve elevation focusing. (E and F) Images of the front (E) and back (F) sides of the
custom-made PCB.

Figure 1.7: In vivo multimodal PET, MRI, TRUSPA imaging of the prostate in a patient with PCa
(from Ref. [29]). In all images, the rectum (R), rectal wall (RW), bladder (B), anterior
fibromuscular stroma (AFS), and prostate (P; green contour) are labeled. (A to C) Ultrasound (US)
in grayscale, PA in red color scale, and co-registered US + PA images of human prostate obtained
in vivo with the TRUSPA device. (D) Axial PET imaging showing PCa (yellow contour) using
68

Ga-labeled radioactive tracer targeting bombesin receptor on the PCa cells. (E) Axial MRI

showing anatomical information of the prostate with yellow contour covering the extent of PCa
identified using PET molecular imaging. (F) Axial TRUS image showing targeted region (yellow
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contour) for biopsy using the data from both MRI and PET; targeted biopsy confirmed PCa. (G)
Final histopathology from the prostatectomy showing areas of hypervascularity (arrows within)
the tumor. Scale bar, 10mm.

Thyroid Imaging
Thyroid cancer is over diagnosed and over treated. Ultrasonography, in combination with fine
needle aspiration cytology (FNAC) followed by histology, is the primary diagnostic tool for
thyroid cancer. Kang et al. evaluated the diagnostic utility of PAI at detecting thyroid
microcalcifications at 700 nm laser wavelengths including 36 resected samples in 18 patients [49].
Dogra et al. validated that ex vivo multispectral photoacoustic imaging can be used to differentiate
malignant tissue, benign nodules, and normal human thyroid tissue including fifty patients
undergoing thyroidectomy [50]. Yang et al. reported an initial clinical study of in vivo human
thyroid by a photoacoustic/ultrasound handheld probe [11]. Both healthy and cancerous thyroids
were imaged non-invasively and they compared the photoacoustic imaging with color Doppler
ultrasound. The results of photoacoustic thyroid imaging could reveal many blood vessels that
were not sensitive for Doppler ultrasound. As shown in Figure 1.8, Roll et al. evaluated hybrid
multispectral optoacoustic tomography/ultrasound for imaging thyroid disorders, including
Graves’ disease and thyroid nodules [10]. The functional biomarkers and tissue parameters
deoxygenated hemoglobin, oxygenated hemoglobin, total hemoglobin, saturation of hemoglobin,
fat content, and water content were analyzed in thyroid lobes affected by Graves’ disease, thyroid
lobes with healthy tissue, benign thyroid nodule, and malignant thyroid nodules. This pilot study
showed

the

applicability

and

the

potential

of

hybrid

multispectral

optoacoustic

tomography/ultrasound to semiquantitatively provide tissue characterization and functional
parameters in thyroid disorders for improved noninvasive diagnostics of thyroid diseases.
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Figure 1.8: Principles of clinical MSOT of thyroid (from Ref. [10]). (A) Scheme of examination
of thyroid gland with handheld hybrid MSOT/ultrasound system (left). Patients with thyroid
nodules, healthy individuals, and Graves’ disease patients were scanned in a reproducible setup.
(B) In a first step, MSOT image are acquired for single wavelengths (left). Spectral unmixing,
based on specific absorption spectra of different tissue constituents (right), allows assessment of
functional parameters such as HbR, HbO2, fat content, and water content. (C) Transversal
ultrasound image of thyroid gland and surrounding tissue allows exact localization of anatomic
21

structures (left). ROIs drawn on ultrasound images were transferred to coregistered pseudo colorcoded averaged MSOT images (here, HbT) for visual and quantitative analysis (right).

Dermatologic Imaging
The human skin, being easily accessible, makes it an ideal location for non-invasive imaging. Attia
et al. performed MSOT imaging with two-and three-dimensional handheld scanners on 21 Asian
patients with non-malanoma skin cancers (NMSC) [26]. The tumors and their oxygenation
parameters could be distinguished from normal skin endogenously. The intraclass correlation
coefficient correlating tumor dimension measurements between MSOT and ex vivo histology of
excised tumors, showed good correlation. Real-time 3D imaging was found to provide information
on lesion morphology and its underlying neovasculature, indicators of the tumor’s aggressiveness.
As shown in Figure 1.9, Aguirre et al. demonstrated that raster-scan optoacoustic mesoscopy
(RSOM) implemented in ultra-broadband (10-180 MHz) detection mode bridges the depth
capabilities of ultrasound and the resolution range and high contras of optical methods in clinical
dermatology [24]. They visualized skin morphology and vascular patterns in the dermis and subdermis of psoriasis patients, enabling quantification of inflammation and other biomarkers of
psoriasis without the need for contrast agents. Moreover, Kim et al. performed multispectral ex
vivo photoacoustic imaging of cutaneous melanoma for better selection of the excision margin
[25].
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Figure 1.9: Skin imaging with the portable UB-RSOM system, using color coding of frequency
bands (from Ref. [24]). a, Schematic of the operation of UB-RSOM. The transducer is rasterscanned parallel to the skin surface, acquiring acoustic signals (A lines) that are generated by laser
illumination from two fixed fiber bundles. The focal point of the transducer is kept above the skin
surface. b, Photograph of the scanning head and the articulated arm. c, Photograph of the scanning
head in position, ready for data acquisition. d,e, The collected optoacoustic signals are filtered in
two frequency bands and reconstructed into two images shown in red and green, representing low
and high spatial frequencies, respectively. f, UB-RSOM image of healthy skin which combines
low and high spatial frequencies in a single color-coded image. g-i, Maximum intensity projections
in the coronal direction of the epidermis, showing the indentations of the skin (g), the capillary
loop layer (h) and the dermis (i).

1.3

Co-registered

Photoacoustic

and

Ultrasound

Tomographic Imaging
Our lab has performed co-registered photoacoustic and ultrasound tomographic imaging on human
ovarian cancer for couple of years. Two generations of systems have been developed and applied
to ovarian cancer clinical study [30, 14]. Shown in Figure 1.10, the first generation system
consisted of a laser source, a fiber-optic light delivery system, a transvaginal US probe, and a realtime PAT/US data acquisition and processing module. The laser source, a tunable Ti: Sapphire
laser (LS-2211, Symphotics TII, Camarillo, California) pumped by a Q-swithced Nd: YAG laser
(LS-2134, Symphotics TII), delivers 20 ns pulses at 15 Hz repletion rate. In the fiber-optic light
delivery system, laser light propagates through a single homemade cylindrical lens array (Edmund
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Optics Inc., Barrington, New Jersey). The lenses are arranged with two in front and another two
behind, and positioned orthogonally to the pair in front. With the incident laser light centered on
the lens array, the beam was splitted into four separate and equal spots [51]. Each beam is coupled
into a 1 mm core optical fiber with a numerical aperture of 0. 48. In the transvaginal US probe,
four 1 mm core optical fibers are sandwiched between a 3D printed sheath and a 128-element
transvaginal US array with a 6 MHz central frequency and 80% bandwidth [52]. In the real-time
PAT/US data acquisition and processing module, a unique field-programmable gate array (FPGA)
is used to control, acquire, store, delay-and-sum, and transfer data for real-time co-registered
imaging [53]. The FPGA controls the ultrasound transmission and ultrasound and photoacoustic
data acquisition process of a customized 16-channel module that contains all of the necessary
analog and digital circuits.
Figure 1.11, shows images from a clinical study of 25 excised ovaries from 15 patients.
Additionally, two patients who had suspicious ovarian masses were imaged in vivo four to eight
days before prophylactic oophorectomy. They achieved a sensitivity of 70.4% and specificity of
95.6% using the logistic model whereas as sensitivity of 87.7% and specificity of 97.9% using the
SVM. Moreover, for the two in vivo cases, the logistic classifier accurately identified 12 out of 14
imaging frames from a high-grade, early-stage serous epithelial carcinoma, and all 17 images from
a benign ovarian mass.
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Figure 1.10: The first generation transvaginal coregistered photoacoustic/ultrasound imaging
system located at the Radiology Department of the UCONN Health Center for patients’ studies
(from Ref. [30]).
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Figure 1.11: (a) In vivo coregistered PAT/US image of a postmenopausal ovarian mass, (b) ex
vivo coregistered PAT/US image of the same ovary after oophorectomy, and (c) photograph of the
ovary. The dashed lines illustrate the 2-D PAT/US scan positions and the corresponding H&E cuts.
(d) H&E staining of the malignant area. The arrows point to the ovary surface. (e) Microvessels
from the rectangular region indicated in (d) (from Ref. [30]).

Shown in Figure 1.12, the second generation system has the same laser source, fiber-optic light
delivery system, and the transvaginal probe as the first. The only difference is the real-time
PAT/US data acquisition and processing module. Instead of using the home-made module, we
employed a commercial US system from Alpinion Inc. The Alpinion system provides channel data
for both US pulse-echo and photoacoustic imaging, and it can be programmed as a computer
terminal for displaying US and photoacoustic images side by side or in co-registered mode.
Using the second generation system, between February 2017 and December 2017, we did another
round of in vivo clinical study, including 26 ovarian masses from 16 participants, as shown in
Figure 1.13. The average rHbT was 1.9 times higher for invasive epithelial cancers than for the
benign/normal ovaries (P = .01). Additionally, the rHbT distribution was extensive in invasive
epithelial cancers, but was scattered in benign/normal ovaries. However, the rHbT values of two
borderline serous tumors and one stromal tumor were in the same range as that of benign/normal
ovaries. The mean sO2 of invasive epithelial cancers, and of the borderline and stromal tumors,
was 8.2% lower than that of benign/ normal ovaries (P = .003). Invasive epithelial ovarian cancers
showed higher and more extensive tumor vascularity and lower oxygen saturation than benign and
normal ovaries. In summary, the coregistered PAT and pulse-echo US was able to distinguish these
features and has great potential to improve diagnostic US.
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Currently, we are recruiting more patients to participate in a screening and high-risk patient
treatment monitoring study at the Washington University School of Medicine.

Figure 1.12: Photograph of the photoacoustic tomography (PAT) and pulse-echo US system used
for patient study (from Ref. [14]). The laser and optical system was sealed inside a metal cover,
with only four fibers coupled to the probe.
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Figure 1.13: Images in a 63-year-old woman after menopause who had a solid right adnexal mass
measuring up to 4.5 cm, ascites, and a thickened endometrium at contrast enhanced CT (patient 3)
(from Ref. [14]). A. Contrast-enhanced CT image. B. US image (EC-12R; Alpinion Medical
Systems) of the right adnexa (arrows). C. The coregistered US and photoacoustic tomography
relative total hemoglobin (rHbT) map shown in color, with extensive diffused vascular distribution
covering a large area of the region of interest in the depth range of 1-4 cm. D. US Doppler image
(Logiq 8S; GE Healthcare) of the right adnexa shows a hypoechoic soft tissue mass with minimal
peripheral flow on color Doppler images (arrows). E, CD31 immunostaining in the suture area,
showing numerous and extensive micro-vessels; F, Oxygen saturation (sO2) map of the region of
interest marked by the white rectangular box in C with mean sO2 of 43.2%. G, US image in the
left ovary (arrows). H, Coregistered US and photoacoustic tomography rHbT map shows scattered
photoacoustic tomography signals. I, CD31 immunostaining of surgical sample. J, sO2 map of the
region of interest identified by coregistered US with measured mean sO2 of 58.2%. Pathologic
examination found a normal ovary with no significant histopathologic abnormalities.
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Chapter 2: Optimize a light delivery probe,
using ball lenses for co-registered
photoacoustic and ultrasound endo-cavity
subsurface imaging
2.1 Introduction
Adenocarcinoma is a type of cancerous tissue that forms in mucus-secreting glands throughout the
body. For example, adenocarcinomas make up around 96% of colorectal cancers, and some
cervical cancers (10%) are also adenocarcinomas [1-4]. The depth of invasion for early stage
adenocarcinoma is generally around 1 mm to 7 mm. For example, the stromal invasion depth for
cervical adenocarcinoma was measured to be 5 mm or less from the base of the epithelium, with a
horizontal spread of 7 mm or less by microscopy [5]. Currently, magnetic resonance imaging
(MRI) is the best available imaging modality for detecting and surveilling these tumors, however,
its resolution is limited, hindering imaging of small malignancies or abnormalities. Computed
tomography (CT) and positron emission tomography (PET) are primary modalities for evaluating
tumor metastasis, but are limited in their ability to locally stage malignancies [6]. Clearly, a noninvasive imaging technique is needed to provide high tumor contrast at reasonable microscale
resolution and clinically relevant depths.
Photoacoustic imaging or tomography (PAI or PAT) is an emerging technique that can provide
functional information about biological tissues [7-16]. Optical absorption, the main PAT contrast,
is directly related to tumor angiogenesis and tumor hypoxia. Tumor angiogenesis and oxygen
consumption are significant indicators for tumor growth, metastasis, and therapeutic response [1718]. By combining PAT with ultrasound (US), a PAT/US dual-modality imaging system can
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simultaneously provide anatomical and functional information about tumors [19-22].Optical fiber
based photoacoustic imaging probes have been designed for various applications by several
research groups [23-33]. Linear ultrasound transducer array based PAT probes with either a darkfield illumination scheme [29-31] or a bright-field scheme [32-33] have also been investigated.
However, the large sizes of the US array and the high loss in the light transmission of the employed
fiber bundles [28-33] make these probes unsuitable for endo-cavity PAT/US imaging. Our group
has designed several optical fiber-based transvaginal PAT/US imaging probes for ovarian cancer
diagnosis [34-35]. In one early study, the probe consisted of 36 fibers, each with a 200 micron core
diameter, paired with a custom-made high-power fiber-optic beam splitter assembly that was
integrated with a commercial transvaginal ultrasound transducer and housed in a protective shield.
However, the custom-made beam splitter was expensive and easily damaged at the splitter junction
by the high energy involved. A later design was modified to use four multi-mode optical fibers
with 1 mm core diameters. To eliminate potential hotspots and homogenize the light output of the
four fibers, the fibers were enclosed in a custom-designed sheath. The sheath was made of
acrylonitrile butadiene styrene (ABS), constructed with a 3D printer, and internally lined with an
aluminized film with a reflection coefficient of 85%. The sheath gradually tapered towards the exit
end of the probe to allow easy penetration into the body cavity and optimize light homogeneity. In
this later design, the 8 to 10 mm thick vagina muscle wall functioned as the light diffuser to
homogenize the light beam before it reached the ovary. However, the light beam was not optimized
for endo-cavity imaging of surface tumors, such as adenocarcinomas.
Commonly used lens components in fiber-optic microprobes include gradient-index (GRIN) lenses
[36-37], drum lenses [38], and fiber fused ball lenses [39-40].
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In this paper, we report the optimal design, implementation, and evaluation of an optical fiber
based transvaginal PAT/US imaging probe for endo-cavity imaging of adenocarcinomas. A ballshaped lens is glued to each of four fiber tips to homogenize the light illumination on the tissue
surface. The light delivery system consists of light coupling optics, a custom-made transducer
sheath, and four 1 mm core multi-mode optical fibers, each with a ball-shaped lens glued on its
tip. The endo-cavity illumination design was simulated for various numerical apertures (NA),
refractive indexes, probe taper angles, and fiber distances from the tip of the probe, and was
subsequently validated by experimental measurements.

2.2 Methods and Materials
2.2.1 Experiment Setup and Imaging Probe
Shown in Figure 2.1 (a), the co-registered PAT/US system consists of a Ti:Sapphire (Symphotics
TII, LS-2122, Symphotics, Camarillo, California) optically pumped with a Q-switched Nd:YAG
laser (Symphotics TII, LS-2134) to deliver pulsed laser light (10 ns pulse duration, 15 Hz pulse
repetition rate, 20 mJ/pulse at 750 nm wavelength). Four fibers receive light from the laser through
an optimized illumination system [41]. A commercial US system (EC-12R, Alpinion Medical
System, Republic of Korea) is used to acquire the corresponding US and PAT data.
To deliver light to the imaged tissue, the imaging probe was constructed based on the optimal
parameters obtained from the simulation. Four 1 mm core multi-mode optical fibers (FP1000ERT,
0.50 NA, THORLABS, n = 1.4 in the 700-800 nm wavelength range) were housed in four
corresponding slots on the inner surface of the sheath and sandwiched between the sheath and a
128-channel curved trans-vaginal US transducer (central frequency: 6 MHz, 80% bandwidth). A
custom-designed 3D printed sheath, shown in Figure 2.1 (b), was made of photopolymer
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(RGD525). The inner surface of the sheath and the outer surface of the ultrasound transducer were
covered with an aluminized film having a reflection coefficient of 85% at 750 nm wavelength.
Four ball lenses (1.5-mm-diameter, n = 1.517, Edmund Optics, N-BK7) were individually glued
(Norland Optical Adhesives, Edmund Optics) to the ends of 1 mm core multi-mode optical fibers,
as shown in Figure 2.1 (c).

Figure 2.1: (a) Light delivery path of PAT/US system. (b) Zoomed-in view of the imaging probe
illustrating co-registered PAT/US transducer with cover sheath and transducer inside sheath. (c)
Transducer face with four ball-shaped fiber tips (red color). Insert is the enlarged optical fiber with
ball-shaped fiber tip.

2.2.2 Optimization of Imaging Probe Design
Our co-registered US and photoacoustic probe design was optimized to refine its shape and to
achieve uniform light homogeneity on the tissue surface, high fluence levels, however, below the
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ANSI safety limit (~25 mJ/cm2 in the 700-800 nm wavelength range) [42], and acceptable power
output efficiency. Two sets of simulations were performed as described below.
Using a 3D model in Zemax software, the first set of simulations was performed by measuring the
subsurface fluence distribution of the four fibers with and without ball-shaped lenses on the fiber
tips. The model of the imaging probe, shown in Figure 2.2, consisted of two concentric hollow
cylinders with diameters of 20 mm and 25 mm, which represented the transvaginal US transducer
and the probe sheath, respectively. For the inner cylinder, the front face was a convex curvilinear
shape with a rectangular cross-section, representing a typical transvaginal or transrectal transducer
front face. The light tunnel formed between the inner surface of the outer cylinder and the outer
surface of the inner cylinder was assigned a reflection coefficient of 85% at 750 nm, which is the
reflection coefficient of typical aluminized film. The power output efficiency is defined as the ratio
of the total energy output from the probe to the total energy exiting the four fibers.
A ball-shaped lens on the fiber tip increases fiber’s effective NA. The original fiber’s NA was 0.5
without a ball lens, and the ball lens of radius 0.75 mm at the fiber tip increased the NA up to 1.2.
The ball-shaped lens also improved the light fluence, this is due to light refocusing at a short
distance in front of the ball lens. The position of the focal point for ball-shaped fibers was
calculated using paraxial theory [43-45]: F = Rball*nmedium/(nball-nmedium) = 5.33 mm, where F is the
distance of the distal focal point from the surface of the tip (radius of ball tips, R ball =0.75 mm;
refractive index, nball = 1.517) in the medium (refractive index, nmedium = 1.33). The position of the
focal point is related to the radius of the sphere, the refractive index of the medium, and the
refractive index of the ball lens.
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Several parameters of the imaging probe were investigated in order to obtain light illumination
homogeneity and acceptable fluence levels, while at the same time yielding higher power output
efficiencies. These parameters, some of which are shown in Figure 2.2 include 1) the ball lens
refractive index (n); 2) fiber numerical aperture (NA); 3) fiber displacement from the probe tip
(L); and 4) sheath taper angle (θ).
The divergence angle of the light exiting the fiber depends on the fiber’s NA, which was simulated
in Zemax by adjusting the divergence of the light source corresponding to the fiber NA that would
give the same divergence. Six different NA, with values of 0.5, 0.7, 0.9, 1.0, 1.1, and 1.2 were
simulated.
The focus distance of a ball lens depends on ball lens’s diameter, refractive index and the medium
refractive index. The converging waist and the diverging angle of the ball lens depend on the ratio
between the ball lens diameter and the fiber’s diameter [43-45]. The original fiber’s NA, refractive
index, and diameter were 0.5, 1.4, and 1.0 mm respectively. The ball lens’s refractive index was
simulated in Zemax by adjusting the material of the lens while keeping the lens diameter fixed at
1.5 mm. Six different refractive indexes, of 1.45, 1.51, 1.6, 1.68, 1.77, and 1.87 were simulated.
The fiber displacement (L) was also varied in Zemax: displacements of 2.5, 5, 7.5 and 10 mm from
the probe tip were simulated. For each displacement, the fluence and power output efficiency at
the imaging plane were simulated for all the NA values and compared. The simulation results were
obtained with the sheath diameter fixed at 25mm and the sheath taper angle at 0o. The sheath taper
angle (θ) was variously set at 0o, 4o, 7o, 11o, 12o, 12.5o, 14o, 17o, 21o, and 24o. These angles were
simulated by fixing the taper height (H) at 8 mm and changing D1 from 9 to 12.5 mm, and were
simply calculated from the inverse tangent of the ratio (D-D1)/H (Figure 2.2). The simulation
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results were obtained with a beam divergence corresponding to a fiber NA of 1.2 and a
displacement of 2.5 mm.
In the second set of simulations, to simulate a muscle wall, the probe was submerged inside a 100
mm deep volume of medium with a reduced scattering coefficient (μ′s ) of 4 cm−1 and absorption
coefficient (μa ) of 0.02cm−1 . The resulting fluences at twelve different depths from 2.5 mm to 30
mm with 2.5 mm interval were compared. Please note that the depths are defined as the distance
from the probe base to the detector plane as shown in Figure 2.2.

Figure 2.2: Model of the imaging probe employed in the simulation, with all design parameters
shown. L, fiber displacement; D, sheath diameter; and θ, sheath taper angle. The detector plane is
used in Zemax simulation to observe the light fluence.
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2.2.3 Performance Evaluation
In order to validate the system performance [46], we conducted five sets of experiments using the
setup shown in Figure 2.3. In the first experiment, we evaluated the light delivery efficiency using
fibers with ball tips. The performance of the PAT probe with the original fiber tips and ball-shaped
fiber tips was compared by measuring the PAT signals coming from a 400 µm diameter black
thread parallel to the imaging plane submerged in a water tank filled with calibrated intralipid
solution (Fresenius Kabi, USA). We measured signals at 12 different depths, from 2.5 to 30 mm,
at 2.5 mm intervals and 780nm. The intralipid solution had a reduced scattering coefficient (μ′s ) of
4 cm−1 and an absorption coefficient ( μa ) of 0.02 cm−1 . Next, we evaluated the fluence
homogeneity using the ball-shaped fiber tips. We captured the laser fluence distributions at 780
nm at four different depths of calibrated intralipid solution (5, 10, 15, 20 mm), using a 12 bit CCD
camera (Basler ace, 30 fps, dynamic range 57 dB), and compared the results with those for the
original fiber tips. Subsequently, we buried sets of 400 μm black threads parallel to the imaging
plane inside chicken breast tissue at five different depths, from 5 to 15 mm at 2.5 mm intervals,
and imaged them at 780 nm. For each measurement, after coupling gel was applied, the probe was
placed in contact with the chicken breast surface. The performance of the PAT probe with the
original fiber tips and ball-shaped fiber tips was compared by measuring the PAT signal strengths
from the black threads at each depth. Next, a freshly resected colorectal cancer tissue sample was
imaged immediately, after surgical excision from a patient at Washington University School of
Medicine. The performance of the PAT probe with the original and ball-shaped fiber tips was
compared by measuring the PAT signals at 780 nm, which came from tumor absorption inside the
colon sample. Finally, a palmar vein proximal to the human wrist at a depth of around 1-3 mm and
parallel to the imaging plane was imaged in a healthy volunteer. The performance of the PAT
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probe with the original and ball-shaped fiber tips was compared again by measuring the PAT
signals from blood absorption at 780 nm.

Figure 2.3: The experiment setup for measuring the PAT signal from a black thread inside
calibrated intralipid solution and recording the light fluence profile. The US system is shown on
the left and the detection camera is underneath the intralipid solution with a film to hold the
intralipid. The same set-up is also used for measuring PAT signals with the black thread imbedded
inside the chicken breast tissue (not show).
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2.3 Results
2.3.1 Simulation Results
Four parameters were sequentially simulated and optimized to test the performance of the endocavity illumination design: the fiber’s effective NA, the refractive index of the ball lens, the sheath
taper angle, and the fiber displacement.
Fiber NA: The effects of using fibers with different NAs on the light fluence are shown in Figure
2.4 (a). As the NA increases, the maximum fluence and power output efficiency decrease, as shown
in Figure 2.4 (b). However, increasing the divergence of the light exiting the fiber in turn increases
the reflection of photons, resulting in a more diffuse and homogenized beam. For ball-shaped fiber
tip, 5 different radii of 0.6, 0.65, 0.75, 0.85, 0.95 mm were investigated. The 2D fluence profile
and the corresponding 1D profile taken along the horizontal direction were recorded at the
detection plane at 7 mm away from the ball-shaped fiber tip. The full width at half maximum
(FWHM) after Gaussian fitting of the corresponding 1D profile was used to calculate the ballshaped fiber tip’s NA. Based on the simulation, we selected an NA of 1.2 for the following ball
tip design. Calculations showed that a 0.75 mm radius ball tip optimally increased the 1.0 mm
diameter fiber’s effective NA, from 0.5 to 1.2 as shown in Figure 2.5.
Ball lens refractive index (n): The effects of using ball lenses with different refractive indexes
on the light fluence are shown in Figure 2.6. As the refractive index increases, the light fluence
decreases, a consequence of the fiber’s refractive index of 1.4. As ball lens’ refractive index
increases, the mismatch of refractive index between the original fiber and ball lens results in more
back scattered light. Based on the simulation, we determined to use n = 1.45-1.52 to be the
refractive index range with the highest fluence.
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This study is evaluating three major parameters: fluence homogeneity and level on tissue surface,
and power output efficiency.

For lesions on the surface, the fluence homogeneity is a critical

parameter to make sure the illumination pattern is uniform with no hot spots. Based on the
simulation, we choose NA=1.2. We then consider trade-off between fluence level, power output
efficiency and other probe design parameters. For example, we found other optimal parameters
such as refractive index n=1.45-1.52 provided the highest fluence, 2.5 mm displacement provided
the highest fluence and output power efficiency. For the taper angle, we choose 12.5 degree for
the highest fluence and relatively high power output efficiency because in this condition, fluence
and power output efficiency cannot achieve the highest performance simultaneously.
Second set of simulations: In a second set of the simulations, we examined the relationship
between the distance of the optical detection plane from the fiber tips and the central area light
fluence at the detection plane. Figure 2.7 shows the results for an original fiber tip (NA = 0.5,
displacement = 5 mm) and a 0.75 mm radius ball-shaped fiber tip (NA = 1.2, displacement = 2.5
mm). At less than 13 mm distance, the central fluence from the ball tip is much higher than that
from the original fiber tip, indicating an increased NA and improved light homogeneity. For
distances greater than 13 mm, the fluence at the central imaging area underneath the probe of the
original fiber setup is higher than with the ball-shaped fiber setup. With the original fiber, the light
beam is homogenized by penetrating through the scattering medium, and the lower NA can
decrease light scattering events. However, since more photons are scattered when the distance
between the fibers and the detection plane increases, the fluence in the central area decreases for
both the ball tip setup and the original fiber setup.
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Figure 2.4: Simulated fluence profile corresponding to different fiber NA values. The dashed
rectangle represents the cross section of the transducer front surface. (b) The laser fluence and
power output efficiency corresponding to fiber NAs of 0.5, 0.7, 0.9, 1.0, 1.1, and 1.2.

Figure 2.5: The relationship between the radius of ball lens and effective NA.
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Figure 2.6: The laser fluence corresponding to ball lens refractive index of 1.45, 1.51, 1.6, 1.68,
1.77, and 1.87.

Figure 2.7: Simulated fluence in the central imaging area with the original fiber tip and 0.75 mm
radius ball-shaped fiber tip, corresponding to detection plane depths from 2.5 to 30 mm, at 2.5 mm
intervals.

2.3.2 Experimental Results
Figure 2.8 shows the PAT signals measured from a 400 µm diameter black thread parallel to the
imaging plane at 12 different depths inside a water tank filled with calibrated intralipid solution.
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The average peak value of 20 consecutive central beamline envelopes within the region of interest
(ROI) was calculated for each distance. For imaging depths shallower than 15 mm, PAT signals
from the ball tips are higher than those from the original fiber tips. At depths deeper than 15 mm,
the PAT signals from the original fiber tips are higher since the beam is homogenized and the
lower NA limits the divergence of the beam and delivers higher fluence. However, as the depth
increases, the PAT signals from both tips drops, which is consistent with the previous simulation.
The fluence delivered by the probe after light propagation through 5-20 mm thicknesses of
intralipid solution are shown in Figure 2.9 (a). As the thickness increases, the light fluence
distribution from ball tips becomes more uniform than that from the original fiber tip setup,
especially up to a thickness of 10 mm. In order to quantitatively evaluate uniformity, we use a
merging factor (M =

MaxFluence−CenterFluence
MaxFluence

) [34] as shown in Figure 2.9 (b). Compared with the

original fiber setup, the ball tips’ merging factor is lower for each depth; that is, the beams merge
faster and the light fluence distribution becomes more uniform in the photoacoustic imaging.
Uniform light illumination over the imaged area is important to obtain an accurate representation
of the light absorption map.
The PAT signals coming from a set of 400 μm diameter black threads parallel to the imaging plane
and buried inside chicken breast tissue at five different depths are shown in Figure 2.10. The
average peak value of 20 consecutive central beamline envelopes within ROI was calculated for
each distance. At depths shallower than 11mm, the PAT signals from the ball tips are higher than
from the original fiber tips, and at deeper imaging depths, the PAT signals from the original fiber
tips are higher. Also, with the increasing depth, the PAT signals in both cases drop, similar to the
previous simulation and measurements with the black thread inside intralipid solution. This
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behavior implies that within an imaging depth of 10 mm, the PAT probe with ball-shaped fiber
tips can achieve a higher light delivery efficiency in the central imaging area underneath the probe.
PAT signals from fresh human colorectal cancer tissue, parallel to the imaging plane at around 3
mm depth, were shown in Figure 2.11. We note here that this study was approved by Institutional
Review Committee and the patient signed an informed consent document. The average peak value
of 30 consecutive central beamline envelopes within the ROI was calculated. The PAT signals
from the ball-shaped fiber design are higher than the original fiber setup within this depth range.
Hence the PAT probe with a ball-shaped fiber tip has a better light delivery efficiency in the central
imaging area underneath the probe and transducer, maximizing the sensitivity of the design.
PAT signals coming from a palmar vein proximal to a human wrist, parallel to the imaging plane
at around 1-3 mm depth, are shown in Figure 2.12. The average peak value of 20 consecutive
central beamline envelopes within the ROI was calculated. The PAT signals from the ball tip
design are higher than from the original fiber setup within this depth range, which is consistent
with the results of the human colon cancer sample.
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Figure 2.8: The experimental laser output power on a 400 µm black thread inside calibrated
intralipid solution with the original fiber tip and a 0.75 mm radius ball-shaped fiber tip. Different
depths between the fiber tip and the black thread are shown, from 2.5 to 30 mm, at 2.5 mm
intervals.

Figure 2.9: Experimental light fluence profiles through calibrated intralipid solution corresponding
to different distances. (a) The fluence profile pattern through intralipid solution and (b) the
corresponding 1D profile taken along the middle intersection in the horizontal direction at
thickness of 5, 10, 15, and 20 mm, and (c) calculated merging factor versus depth.
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Figure 2.10: The experimental laser output power on a set of five 400 μm diameter black threads
buried inside chicken breast tissue at depths of 5, 7.5, 10, 12.5 and 15 mm.
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Figure 2.11: Color photograph of fresh human colon cancer tissue: (a) the dashed square box
outlines the lesion region and the white arrow indicates the direction along which several B-scans
were recorded. (b) Ex-vivo photoacoustic imaging of human colorectal cancer with the original
fiber tip and (c) the ball-shaped fiber tip. (d) Corresponding PAT signals from the same ROI (white
dashed line).

Figure 2.12: In-vivo photoacoustic imaging of one palmar vein proximal to the human wrist with
(a) the original fiber tip and (b) the ball-shaped fiber tip. (c) Corresponding PAT signals from the
same ROI (white dashed line).
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2.4 Discussion and Summary
This study is evaluating three major parameters: fluence homogeneity and level on tissue surface,
and power output efficiency.

For lesions on the surface, the fluence homogeneity is a critical

parameter to make sure the illumination pattern is uniform with no hot spots. Based on Fig. 4, we
choose NA=1.2. We then consider trade-off between fluence level, power output efficiency and
other probe design parameters. For example, we found other optimal parameters such as refractive
index n=1.45-1.52 provided the highest fluence, 2.5 mm displacement provided the highest fluence
and output power efficiency. For the taper angle, we choose 12.5 degree for the highest fluence
and relatively high power output efficiency because in this condition, fluence and power output
efficiency cannot achieve the highest performance simultaneously.
The proposed ball-shaped fiber tip design increases the fiber’s NA, improving light homogeneity
and increasing the light delivery fluence on the central imaging area, although there is a decrease
in the maximum light fluence on the entire area. Nevertheless, the increased light homogeneity
provides acceptable fluence within the ROI under the MPE for patient safety.
In future studies, fabricating the ball-shaped fiber tip directly from the original fiber end, instead
of gluing the ball lens to the fiber ends, can yield a more Gaussian laser beam distribution.
Moreover, customized micro fiber diffusers [47] can be explored.
The proposed co-registered photoacoustic and ultrasound probe with ball-shaped fiber tips for
optimal light delivery has many clinical applications, especially for cancer diagnosis, staging and
treatment assessment of surface tumors of internal organs. For example, colorectal cancers start
from neoplastic growth from the inner surface of the colon and can penetrate to deeper layers of
the colon at late stages. Cervical cancers arise from the cervix and can grow from the surface of
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the cervix into deeper tissues of the cervix. The cancer may also be growing into the body of the
uterus.

Accurate diagnosis and staging on cancer invasive depth and repeated assessment of

cancer treatment response of these surface cancers are current challenges and research
opportunities. The utility of the proposed co-registered photoacoustic and ultrasound probe in
these applications will be further explored in the near future.
In summary, we have demonstrated a hand-held endo-cavity photoacoustic/ultrasound probe using
ball-shaped fiber tips for noninvasive imaging of human adenocarcinoma. The improved light
homogeneity and increased fluence on the central imaged area make the designed probe suitable
for in vivo noninvasive subsurface tissue imaging.

References
1. B.W. Stewart, C.P. Wild, World cancer report 2014, World Heal. Organ. (2014).
doi:9283204298.
2. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, J. Cain, F.A.R.
Garcia, A.T. Moriarty, A.G. Waxman, D.C. Wilbur, N. Wentzensen, L.S. Downs, M.
Spitzer, A.B. Moscicki, E.L. Franco, M.H. Stoler, M. Schiffman, P.E. Castle, E.R. Myers,
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and
American Society for Clinical Pathology screening guidelines for the prevention and early
detection

of

cervical

cancer,

Am.

J.

Clin.

Pathol.

(2012).

doi:10.1309/AJCPTGD94EVRSJCG.
3. X. Castellsagué, M. Diaz, S. de Sanjosé, N. Muñoz, R. Herrero, S. Franceschi, R.W.
Peeling, R. Ashley, J.S. Smith, P.J.F. Snijders, C.J.L.M. Meijer, F.X. Bosch, M. Plummer,
56

V. Moreno, P. Alonso de Ruiz, S. Chichareon, C. Ngelangel, J. Eluf-Neto, A. Roló, E.
Caceres, C. Santos, N. Chaouki, B. El Gueddari, D. Hammouda, T. Rajkumar, Worldwide
human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications
for screening and prevention, J. Natl. Cancer Inst. (2006). doi:10.1093/jnci/djj067.
4. M.J.

Mäkinen,

Colorectal

serrated

adenocarcinoma,

Histopathology.

(2007).

doi:10.1111/j.1365-2559.2006.02548.x.
5. N. Colombo, S. Carinelli, A. Colombo, C. Marini, D. Rollo, C. Sessa, Cervical cancer:
ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann. Oncol.
(2012). doi:10.1093/annonc/mds268.
6. S.P. Raman, Y. Chen, E.K. Fishman, Evolution of imaging in rectal cancer: Multimodality
imaging

with

MDCT,

MRI,

and

PET,

J.

Gastrointest.

Oncol.

(2015).

doi:10.3978/j.issn.2078-6891.2014.108.
7. R.A. Kruger, P. Liu, Y.R. Fang, C.R. Appledorn, Photoacoustic ultrasound (PAUS)—
Reconstruction tomography, Med. Phys. (1995). doi:10.1118/1.597429.
8. L. V. Wang, H-I. Wu, Biomedical optics: Principles and imaging, wiley, New York, 2007.
9. L. V. Wang, Prospects of photoacoustic tomography, Med. Phys. (2008).
doi:10.1118/1.3013698.
10. X. Wang, Y. Pang, G. Ku, X. Xie, G. Stoica, L. V. Wang, Noninvasive laser-induced
photoacoustic tomography for structural and functional in vivo imaging of the brain, Nat.
Biotechnol. (2003). doi:10.1038/nbt839.

57

11. A.A. Oraevsky, A.A. Karabutov, Ultimate sensitivity of time-resolved optoacoustic
detection, in: Proc. SPIE, 2000. doi:10.1117/12.386326.
12. B.T. Cox, P.C. Beard, Fast calculation of pulsed photoacoustic fields in fluids using k space methods, J. Acoust. Soc. Am. (2005). doi:10.1121/1.1920227.
13. A.A. Karabutov, E. V. Savateeva, N.B. Podymova, A.A. Oraevsky, Backward mode
detection of laser-induced wide-band ultrasonic transients with optoacoustic transducer, J.
Appl. Phys. (2000). doi:10.1063/1.372127.
14. G. Ku, X. Wang, G. Stoica, L. V. Wang, Multiple-bandwidth photoacoustic tomography,
Phys. Med. Biol. (2004). doi:10.1088/0031-9155/49/7/018.
15. L. Yin, Q. Wang, Q. Zhang, H. Jiang, Tomographic imaging of absolute optical absorption
coefficient in turbid media using combined photoacoustic and diffusing light
measurements, Opt. Lett. (2007). doi:10.1364/OL.32.002556.
16. L. Lin, P. Hu, J. Shi, C.M. Appleton, K. Maslov, L. Li, R. Zhang, L. V. Wang, Singlebreath-hold photoacoustic computed tomography of the breast, Nat. Commun. (2018).
doi:10.1038/s41467-018-04576-z.
17. N. Weidner, J.P. Semple, W.R. Welch, J. Folkman, Tumor angiogenesis and metastasis-correlation

in

invasive

breast

carcinoma.,

N.

Engl.

J.

Med.

(1991).

doi:10.1056/NEJM199101033240101.
18. P. Vaupel, F. Kallinowski, P. Okunieff, Blood flow, oxygen and nutrient supply, and
metabolic microenvironment of human tumors: a review., Cancer Res. (1989).
doi:10.1158/0008-5472.can-07-5575.
58

19. H.S. Salehi, H. Li, A. Merkulov, P.D. Kumavor, H. Vavadi, M. Sanders, A. Kueck, M. a.
Brewer, Q. Zhu, Coregistered photoacoustic and ultrasound imaging and classification of
ovarian

cancer:

ex

vivo

and

in

vivo

studies.,

J.

Biomed.

Opt.

(2016).

doi:10.1117/1.JBO.21.4.046006.
20. T. Wang, Y. Yang, U. Alqasemi, P.D. Kumavor, X. Wang, M. Sanders, M. Brewer, Q.
Zhu, Characterization of ovarian tissue based on quantitative analysis of photoacoustic
microscopy images, Biomed. Opt. Express. (2013). doi:10.1364/BOE.4.002763.
21. H. Li, P. Kumavor, U. Salman Alqasemi, Q. Zhu, Utilizing spatial and spectral features of
photoacoustic imaging for ovarian cancer detection and diagnosis, J. Biomed. Opt. (2015).
doi:10.1117/1.JBO.20.1.016002.
22. T. Wang, S. Nandy, H.S. Salehi, P.D. Kumavor, Q. Zhu, A low-cost photoacoustic
microscopy system with a laser diode excitation, Biomed. Opt. Express. (2014).
doi:10.1364/BOE.5.003053.
23. V. Neuschmelting, N.C. Burton, H. Lockau, A. Urich, S. Harmsen, V. Ntziachristos, M.F.
Kircher, Performance of a Multispectral Optoacoustic Tomography (MSOT) System
equipped with 2D vs. 3D Handheld Probes for Potential Clinical Translation,
Photoacoustics. (2016). doi:10.1016/j.pacs.2015.12.001.
24. L. Song, K. Maslov, K.K. Shung, L. V. Wang, Ultrasound-array-based real-time
photoacoustic microscopy of human pulsatile dynamics in vivo, J. Biomed. Opt. (2010).
doi:10.1117/1.3333545.

59

25. J. Hui, Y. Cao, Y. Zhang, A. Kole, P. Wang, G. Yu, G. Eakins, M. Sturek, W. Chen, J.X.
Cheng, Real-Time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in
human coronary artery at 16 frames per second, Sci. Rep. (2017). doi:10.1038/s41598-01701649-9.
26. P. Wang, T. Ma, M.N. Slipchenko, S. Liang, J. Hui, K.K. Shung, S. Roy, M. Sturek, Q.
Zhou, Z. Chen, J.X. Cheng, High-speed intravascular photoacoustic imaging of lipid-laden
atherosclerotic plaque enabled by a 2-kHz Barium Nitrite Raman Laser, Sci. Rep. (2014).
doi:10.1038/srep06889.
27. W. Wei, X. Li, Q. Zhou, K.K. Shung, Z. Chen, Integrated ultrasound and photoacoustic
probe

for

co-registered

intravascular

imaging,

J.

Biomed.

Opt.

(2011).

doi:10.1117/1.3631798.
28. G. S. Sangha, N. J. Hale, C. Goergen, Adjustable photoacoustic tomography probe
improves

light

delivery

and

image

quality,

Photoacoustics.

(2018).

doi:10.1016/j.pacs.2018.08.002.
29. C. Kim, T.N. Erpelding, L. Jankovic, L. V. Wang, Performance benchmarks of an arraybased hand-held photoacoustic probe adapted from a clinical ultrasound system for noninvasive sentinel lymph node imaging, Philos. Trans. R. Soc. A Math. Phys. Eng. Sci.
(2011). doi:10.1098/rsta.2010.0353.
30. C. Kim, T.N. Erpelding, L. Jankovic, M.D. Pashley, L. V. Wang, Deeply penetrating in
vivo photoacoustic imaging using a clinical ultrasound array system, Biomed. Opt.
Express. (2010). doi:10.1364/BOE.1.000278.

60

31. B.L. Bungart, L. Lan, P. Wang, R. Li, M.O. Koch, L. Cheng, T.A. Masterson, M. Dundar,
J.X. Cheng, Photoacoustic tomography of intact human prostates and vascular texture
analysis

identify

prostate

cancer

biopsy

targets,

Photoacoustics.

(2018).

doi:10.1016/j.pacs.2018.07.006.
32. Y.-J. Lee, E.-J. Jeong, H.-W. Song, C.-G. Ahn, H.W. Noh, J.Y. Sim, D.H. Song, M.Y.
Jeon, S. Lee, H. Kim, M. Zhang, B.K. Kim, Photoacoustic imaging probe for detecting
lymph nodes and spreading of cancer at various depths, J. Biomed. Opt. (2017).
doi:10.1117/1.JBO.22.9.091513.
33. M. Li, C. Liu, X. Gong, R. Zheng, Y. Bai, M. Xing, X. Du, X. Liu, J. Zeng, R. Lin, H.
Zhou, S. Wang, G. Lu, W. Zhu, C. Fang, L. Song, Linear array-based real-time
photoacoustic imaging system with a compact coaxial excitation handheld probe for
noninvasive

sentinel

lymph

node

mapping,

Biomed.

Opt.

Express.

(2018).

doi:10.1364/BOE.9.001408.
34. P.D. Kumavor, U. Alqasemi, B. Tavakoli, H. Li, Y. Yang, X. Sun, E. Warych, Q. Zhu, Coregistered pulse-echo/photoacoustic transvaginal probe for real time imaging of ovarian
tissue, J. Biophotonics. (2013). doi:10.1002/jbio.201200163.
35. H.S. Salehi, P.D. Kumavor, H. Li, U. Alqasemi, T. Wang, C. Xu, Q. Zhu, Design of optimal
light delivery system for co-registered transvaginal ultrasound and photoacoustic imaging
of ovarian tissue, Photoacoustics. (2015). doi:10.1016/j.pacs.2015.08.003.
36. W.A. Benalcazar, W. Jung, S.A. Boppart, Aberration characterization for the optimal
design of high-resolution endoscopic optical coherence tomography catheters, Opt. Lett.
(2012). doi:10.1364/OL.37.001100.
61

37. X. Li, T.H. Ko, J.G. Fujimoto, Intraluminal fiber-optic Doppler imaging catheter for
structural

and

functional

optical

coherence

tomography.,

Opt.

Lett.

(2001).

doi:10.1364/OL.26.001906.
38. Y. Zhu, N.G. Terry, J.T. Woosley, N.J. Shaheen, A. Wax, Design and validation of an
angle-resolved low-coherence interferometry fiber probe for in vivo clinical measurements
of depth-resolved nuclear morphology, J. Biomed. Opt. (2011). doi:10.1117/1.3520130.
39. V.X.D. Yang, Y.X. Mao, N. Munce, B. Standish, W. Kucharczyk, N.E. Marcon, B.C.
Wilson, I.A. Vitkin, Interstitial Doppler optical coherence tomography., Opt. Lett. (2005).
doi:10.1158/0008-5472.CAN-08-1128.
40. M. Zhao, Y. Huang, J.U. Kang, Sapphire ball lens-based fiber probe for common-path
optical coherence tomography and its applications in corneal and retinal imaging, Opt. Lett.
(2012). doi:10.1364/OL.37.004835.
41. H.S. Salehi, T. Wang, P.D. Kumavor, H. Li, Q. Zhu, Design of miniaturized illumination
for transvaginal co-registered photoacoustic and ultrasound imaging, Biomed. Opt.
Express. (2014). doi:10.1364/BOE.5.003074.
42. L.I.A. Laser Institute of America, ANSI Z136.1: American National Standard for Safe Use
of Lasers, SPIE Med. Imaging. (2007). doi:10.1117/12.2043901.
43. D. Royston, R. Waynant, A. Banks, S. Ramee, C. J. White, Optical properties of fiber optic
surgical tips, Appl. Opt. (1989). doi:10.1364/AO.28.000799.
44. E. Hecht, A. Zajac, Optics Addison-Wesley, Reading, Mass. (1974).

62

45. R.M. Verdaasdonk, C. Borst, Ray tracing of optically modified fiber tips. 1: spherical
probes, Appl. Opt. (1991). doi:10.1364/AO.30.002159.
46. S. Nandy, A. Mostafa, I.S. Hagemann, M.A. Powell, E. Amidi, K. Robinson, D.G. Mutch,
C. Siegel, Q. Zhu, Evaluation of Ovarian Cancer: Initial Application of Coregistered
Photoacoustic

Tomography

and

US,

Radiology.

(2018).

doi:10.1016/j.jretconser.2010.09.009.
47. M. Li, B. Lan, W. Liu, J. Xia, J. Yao, Internal-illumination photoacoustic computed
tomography, J. Biomed. Opt. (2018). doi:10.1117/1.JBO.23.3.030506.

63

Chapter 3: Develop a novel fiber end face
illumination diffuser for endo-cavity
photoacoustic imaging
3.1 Introduction
Capitalizing on developments in laser and ultrasound detection, our earlier studies reported in vivo
transvaginal imaging using co-registered ultrasound and photoacoustic tomography (PAT) [1-4]. To deliver
light into the PAT imaging probe, the multimode fiber is a typical choice. However, the available fiber
diameters and numerical apertures (NAs) are limited, leading to a small divergence angle and a high light
fluence hotspot on the tissue surface. If the fiber is directly in contact with tissue, the light fluence can easily
exceed the maximum permissible exposure (MPE) (~28 mJ/cm2 @ 780 nm) [5]. Although several research
papers have reported methods to reduce the fluence and hotspot at the skin surface [6-8], energy loss and
manufacturing difficulty still remain as significant challenges.
Diffusion is an excellent method to reduce the fluence on the tissue surface, and a fiber diffuser tip is
relatively compact and well suited for endoscopic imaging. Several research papers and patents have
described fiber diffuser tips of various kinds. For example, Lee et al, [9] described a conical air-pocket fiber
tip made by fusing a section of hollow optical fiber using an electric arc-discharge process. The laser beam
entering the air-pocket fiber interface is reflected by total internal reflection that changes its direction
multiple times, thus generating a larger laser spot or even side illumination. Reference [10] formed cracks
on a fiber tip to generate reflections and refractions, thus diffusing light. Reference [11] described a bulletshaped tip for deflecting and refracting light. However, these kinds of shape/structure-based fiber diffusers
are relatively difficult to make in practice, the customized shape and cracks make fiber fragile, and the
scattered light distribution and spot size are difficult to control.
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Also, researchers have tried to use particles or air bubbles as scattering medium for light diffusing. In
reference [12], the author used a spherical shape radiator composed of adhesive and quartz powder, which
is manufactured on the bare fiber core to generate a spherical pattern illumination for photodynamic
therapy. However, this structure needed a large size scattering sphere compared with fiber dimension for a
good spherical pattern scattering effect. Reference [13] described a diffusive tip for phototherapy in surgery
made by optical scattering medium enclosed in a light transmissive cap, which is attached to fiber tip, with
2π steradians illumination. However, for photoacoustic imaging, the large diffusing divergence angle in
references [12,13] is undesirable, where the back-scattered light could not be injected into tissue effectively
and thus utilized for imaging.
To address these problems, we have developed an effective fiber diffuser tip to reduce the fluence on the
target tissue surface, while injecting more laser energy and enhancing the photoacoustic signal generated
from the tissue.

3.2 Methods and Materials
The fiber diffuser tip, as depicted in Figure 3.1(a), is made of silica microspheres (10 um diameter, refractive
index = 1.458) mixed within ultraviolet (UV) adhesive (Norland Optical Adhesive 63, refractive index =
1.56). By simple steering, the mixture can be made. After that, the mixture is set aside or put into a vacuum
chamber for degassing till all the air bubbles in the mixture are gone. Before applying the mixture onto fiber
tip, the homogeneity of mixture is inspected under microscope.
After adhesive mixture preparation, the fiber end facet is polished, and then it is dipped into the mixture
of microspheres and adhesive. A partial sphere tip is thus formed by the surface tension of the
adhesive. After curing for several minutes under UV light exposure, the fiber diffuser tip is
complete. The thickness and curvature of the diffuser tip surface will influence the diffusive effect slightly.
65

In our experiment and simulation, the curvature of the surface is considered as partial sphere, the radius of
the surface is around 0.55 mm and the thickness of the diffuser tip between fiber end and tip end is around
0.32 mm as marked in Figure 3.1(a). When photons enter the tip scattering region, they undergo Mie
scattering caused by the refractive index difference between the microspheres and the surrounding
UV adhesive, thus scattering the photons and reducing the output fluence. This diffuser structure
is compact, with the same dimension as the fiber diameter, and is easy to manufacture in lab.
Here, the diffusing mixture concentration is calculated as the ratio between the mass of the UV
adhesive and the microspheres. For example, a 20:10 diffuser is a mixture of 0.20 grams UV
adhesive and 0.10 grams silica microspheres. On the one hand, with a higher concentration of silica
microspheres, the photons experience more scattering events, and thus light is more diffused at the
output end. On the other hand, when mixing more and more silica microspheres with the UV
adhesive, the solution will eventually become saturated as a clump which is hard to apply onto
fiber tip. A 20:10 ratio is the highest microsphere concentration we could make before the
clumping of microspheres in the UV adhesive.
The measured output cross-sectional patterns of a normal fiber tip and a 20:10 fiber diffuser tip
are shown in Figure 3.1 (b) with the same input laser energy. As can be seen, with the diffuser tip,
a larger spot is observed, and the laser intensity distribution is more homogenized than with the
normal fiber tip output. Figure 3.1 (c) shows the axial output patterns of a normal fiber tip and a
20:10 fiber diffuser tip. The light is diffused fast at the output of 20:10 fiber diffuser tip, while the
laser output of the normal fiber tip is more concentrated to the axis with a smaller divergence angle.
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Figure 3.1: (a) Fiber diffuser tip; (b) Fiber tip output cross-sectional pattern recorded by a camera;
(c) Fiber tip output axial pattern recorded by a camera.

3.3 Results
Another advantage of this fiber diffuser tip is its controllable scattering effect, with varying
microspheres sizes, materials and concentrations. To evaluate the fiber diffuser tip parameters and
scattering effect, simulations were performed to examine the influences of the microsphere size
and material refractive index, as shown in Figure 3.2 (a) and Figure 3.2 (b). Using Zemax’s Mie
scattering model, Figure 3.2 (a) shows the output laser patterns in water of different diffuser tips
made of different microspheres manufactured on 1 mm core diameter multimode fibers (0.5 N.A.,
Thorlabs). To determine by simulation the best scattering effect achievable, we examined the
maximum 20:10 concentrations of microspheres made of commonly used materials, such as sodalime glass (n=1.52), methyl methacrylate (PMMA) (n=1.49), and silica (n=1.458).
As expected, different materials and different microsphere sizes had distinct scattering effects.
Figure 3.2 (b) depicts the output fluence (blue lines) and energy loss (red lines) of different
67

materials with varying microsphere diameters in a water medium. The output fluence here is
defined as the total energy divided by the cross sectional area at the 1/e points (the points where
the fluence has dropped to a value 1/e times the maximum) [5]. The energy loss here is a percentage
defined as the back scattered energy (those energy which does not propagate in the forward
direction after diffuser tip scattering) over the input energy. With smaller microspheres diameter,
the scattering effect is stronger, thus realizing lower output fluence. Meanwhile, energy loss
increases with the reduction of microspheres diameter, especially when the diameter is less than 5
um. Among all the simulated materials, silica microspheres exhibit the best scattering effects but
also have the highest energy loss. By using 10 um diameter silica microspheres (grey dash-dotted
vertical line), a reasonable scattering effect of 6.5 times fluence reduction with acceptable laser
energy loss (< 5%) can be realized.

Figure 3.2: (a) Simulation of fiber diffuser tip output pattern: Normal fiber tip (upper-left), sodalime glass (n = 1.52) (upper-right), PMMA (n = 1.49) (lower-left), silica (n = 1.458) (lower-right);
(b) Comparison of fluence and energy loss of different microsphere materials and sizes.
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The concentration of silica microspheres is another important parameter, which we studied with
both simulations and experiments in water. Figure 3.3 (a) plots fluence (blue lines) and the
maximum input laser energy @ MPE (red lines) variations with different fiber diffuser tip
microspheres concentrations (from 20:0 to 20:10). At the same input energy level (i.e., 4 mJ/pulse
in simulation and experiment), the output fluence drops from around 130 mJ/cm2 for a normal fiber
tip to 20 mJ/cm2 for a 20:10 fiber diffuser tip. On the other hand, with its increased silica
microsphere concentration, the maximum input laser energy without exceeding the tissue surface
MPE also increases, from 0.9 mJ/pulse with a normal fiber tip to 5.7 mJ/pulse with a 20:10 fiber
diffuser tip. This input energy increase will greatly increase the photoacoustic signal without
exceeding the surface MPE due to the diffused laser spot, as will be demonstrated later.
In order to analyze the fiber diffuser tip’s light scattering effect within tissue, we conducted
simulations and experiments using a calibrated 0.4% intralipid solution with a 4 cm -1 reduced
scattering coefficient (µs´) and a 0.02 cm-1 absorption coefficient (µa).
In the experiments, light scattered quickly in the intralipid solution. To show the average fluence
distribution in the intralipid solution, here we defined a parameter, named average energy, as the
total detected energy averaged by the entire energy detector sensing area. Based on this definition,
a higher average energy corresponds to a higher fluence over the energy detector sensing area. In
simulation, the Henyey-Greenstein scattering model in Zemax was applied for simulating
biological tissue, and a 25 mm diameter detector area was used to simulate the 25 mm diameter
energy detector (Coherent Inc., J-25MB-HE) used in our experiment. Figure 3.3 (b) shows both
the simulated and experimental energy distributions at different depths in 0.4% intralipid solution.
The performances of a single 20:10 fiber diffuser tip and a normal fiber tip were compared by
measuring the fluence propagating through 5-50 mm thickness of calibrated intralipid solution.
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During the simulation and experiment, both the 20:10 diffuser tip and normal fiber tip were
controlled at the MPE input energy at the tissue surface. Both the 20:10 diffuser tip and normal
fiber tip showed good agreement between simulation and experiment, with fluence decreasing with
increased depth, due to scattering-induced laser spot expansion. And with the lower laser energy
input, limited by the MPE, the normal fiber (@ 0.9mJ/pulse) shows much weaker average energy
at all depths, nearly 1/6 that of the 20:10 diffuser (@ 5.7 mJ/pulse).
Figure 3.3 (c) depicts the peak fluence depth distribution along fiber axis when the surface fluence
is controlled at the value of MPE. As can be seen in Figure 3.3 (c), with the increase of depth, the
fluence of normal fiber and diffuser tip both decrease. However, with normal fiber, the fluence
along fiber axis decreases much faster than the circumstance with diffuser tip. As marked with the
gray dashed line in Figure 3.3 (c), the peak fluence at 5 cm depth of a diffuser tip is similar to the
peak fluence at 3 cm depth of a normal fiber case.
According to the well-established relationship between photoacoustic signal strength and laser
fluence [14-16], the initial pressure generated by the photoacoustic effect has a linear relationship
with laser fluence and tissue absorption. With a high fluence distribution inside the tissue, a high
photoacoustic signal should be generated under the same tissue absorption parameter. Thus,
according to Figure 3.3 (b) and (c), a stronger photoacoustic signal is expected using a diffuser
with a higher energy input than a normal fiber with limited input energy.
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Figure 3.3: (a) Fluence distribution and maximum input energy with different diffuser
concentrations; (b) Fluence distribution in calibrated intralipid solution at different depths; (c)
Peak fluence along fiber axis at different depths in calibrated intralipid solution.

To demonstrate, we used a 4-fiber transvaginal probe configuration reported in our previous study
[7] to perform the experiment and acquire photoacoustic signal in the calibrated 0.4% intralipid
emulating biological tissue. A carbon fiber was located in different depths as an imaging target.
Also, fluence distribution at different depths was simulated. In this configuration, the horizontal
spacing between fibers was 21mm, and the vertical spacing was 12 mm. The ultrasound probe
(EC3–10, Alpinion Medical Systems, Republic of Korea) was placed in the center of these four
fibers to acquire photoacoustic signal. The fiber tip displacement from the probe base is zero. The
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photoacoustic system setup consisted of a fully programmable clinical US system (EC-12R,
Alpinion Medical Systems, Republic of Korea), and a Nd:YAG laser (Symphotics-TII, LS-2134,
Camarillo, California) pumping a pulsed, tunable (690–900 nm) Ti-sapphire laser (Symphotics TII,
LS-2122). Figure 3.4 (a) and (b) show the simulated laser fluence distributions at different depths
(5-40 mm) inside the calibrated intralipid solution under surface MPE condition, with (a) the
normal fiber and (b) the 20:10 diffuser. Figure 3.4 (c) and (d) depict the normalized fluence
distribution along the dashed diagonal line crossing two hotspots in Figure 3.4 (a) and (b), with (c)
the normal fiber and (d) the 20:10 diffuser. As can be seen, with the 20:10 diffuser, the four laser
spots merged faster than with the normal fiber.
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Figure 3.4: (a) Simulation of four-fiber transvaginal probe output fluence in calibrated intralipid
solution—normal fiber tip; (b) Four-fiber transvaginal probe output fluence in calibrated intralipid
solution—20:10 diffuser tip; (c) Normalized fluence at the diagonal line crossing two hot spots—
normal fiber tip; (d) Normalized fluence at the diagonal line crossing two hot spots—20:10 diffuser
tip.

Figure 3.5 (a) shows the simulated fluence depth information in 0.4% intralipid solution at the
center region of the four fibers, where the imaging target is located, as marked in the white circular
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areas in Figure 3.4 (a) and (b). Based on the simulations, the fluence in intralipid first increases and then
decreases with increasing depth. For the 20:10 diffuser tip, the fluence peak is around 1 cm -- 1.5 cm. For
the normal fiber tip, the peak is at around 1.5 cm -- 2 cm. At 1 cm depth, a 15 dB fluence enhancement
is observed with the 20:10 diffuser (green line, 5.7 mJ/pulse) over that of normal fiber (blue line,
0.9 mJ/pulse). On the contrary, with same laser energy input (4 mJ/pulse), no big difference is
observed in the fluence value distributions of the different diffuser concentrations (purple, orange
lines). Figure 3.5 (b) depicts the experimental results of the recorded amplified photoacoustic signal
from the commercial ultrasound transducer (EC3–10), we see expected similar trends in the
experiments and the simulations.
Figure 3.5 (c) and (d) depict the fluence and photoacoustic signal change with depths in 0.8%
calibrated intralipid solution, which has an 8 cm-1 reduced scattering coefficient (µs´) and a 0.02
cm-1 absorption coefficient (µa). As can be seen, the fluence peak in Figure 3.5 (c) and the
photoacoustic signal peak in Figure 3.5 (d) both shifted down to around 1cm depth in 0.8%
calibrated intralipid solution, due to increased scattering coefficient. Both 0.4% and 0.8%
calibrated intralipid solution experiments show that, with the high concentration 20:10 diffuser tip,
more energy can be injected into the tissue without exceeding the tissue surface MPE, while
generating a higher photoacoustic signal without damaging the tissue surface. In our experiments,
the four-fiber diffuser tips did not reach the MPE energy input level (5.7 mJ/pulse) due to the total
energy limitation of our Ti:sapphire laser, which could reach only 4.5 mJ/pulse per fiber for four
fibers.

74

Figure 3.5: (a) Simulation of four-fiber transvaginal probe fluence distribution in 0.4% calibrated
intralipid solution at different depths; (b) Experiment photoacoustic signal distribution at different
depths in 0.4% calibrated intralipid solution; (c) Simulation of four-fiber transvaginal probe
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fluence distribution in 0.8% calibrated intralipid solution at different depths; (d) Experiment
photoacoustic signal distribution at different depths in 0.8% calibrated intralipid solution.

3.4 Discussion and Summary
The advantages of this fiber diffuser tip include controllability (different diffusion effects
generated by different concentration, material or microsphere size), compactness (same as the
dimension of a fiber tip), compatibility (suitable for various fiber tip with different diameters) and
high feasibility (easy to make in lab with simple procedures and no requirement for expensive
machine). We believe this fiber diffuser tip could be a useful tool for photoacoustic signal
enhancement in many endo-cavity photoacoustic imaging applications, such as in-vivo colorectal
cancer, cervical cancer, and ovarian cancer.
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Chapter 4: Photoacoustic tomography
reconstruction using lag-based delay multiply
and sum with a coherence factor improves in
vivo ovarian cancer diagnosis
4.1 Introduction
Photoacoustic imaging (PAI), also known as optoacoustic imaging (OA), is an emerging
biomedical imaging modality that uses the resolution of ultrasound imaging and the contrast of
optical imaging to provide structural and functional information [1-2]. PAI has demonstrated its
potential for image-based diagnosis in oncology (e.g., breast [3-4], thyroid [5-6], cervical [7],
colorectal [8-9], ovarian [10-11], and prostate cancers [12-13]), peripheral vascular diseases
(PVDs) [14], joint inflammations [15-17], and skin diseases [18-20].
Ranking fifth among fatal cancers affecting women, ovarian cancer accounts for more deaths than
any other cancer of the female reproductive system. According to the American Cancer Society,
about 21,750 women received a new diagnosis of ovarian cancer and about 13,940 women died
from ovarian cancer in 2020 [21]. Due to the lack of early screening and diagnostic techniques,
many women are diagnosed with ovarian cancer when it is already at stages III or IV, where the
mortality rates are high (70 to 75%) [22]. Conventional screening tests, including pelvic
examination [23, 24], transvaginal ultrasound (TVUS) [25, 26], and blood testing for cancer
antigen 125 (CA-125) [26, 27], lack sufficient specificity for early ovarian cancer diagnosis [27].
Imaging modalities such as computed tomography (CT), positron emission tomography (PET),
and magnetic resonance imaging (MRI) have been used for surgical guidance. However, all of
these modalities have limitations in detecting small lesions. In previous work, to address this
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limitation, we developed a co-registered photoacoustic and TVUS technique to improve ovarian
cancer diagnosis [10, 11].
Currently, clinical applications of photoacoustic (PA) or ultrasound (US) imaging most commonly
use the delay and sum (DAS) beamforming algorithm. This algorithm simply sums the properly
delayed and weighted PA/US signal from each channel according to the distances between the
focal points and the detectors. However, it has the drawbacks of low resolution and high side lobes,
resulting in poor reconstructed image quality. Lim et al. first introduced the delay-multiply-andsum (DMAS) image reconstruction algorithm for confocal microwave imaging used for breast
cancer detection [28]. Subsequently, Matrone et al. proposed an improved version of DMAS to
overcome the limitations of DAS in US imaging [29]. Because DMAS improves the coherence of
detected channel data, it provides enhanced image quality, with narrower main lobes, and lower
side lobes than DAS. These advantages have led several researchers to adopt DMAS in PA imaging
and to propose new approaches combining DMAS with other methods. Park et al. combined
DMAS with synthetic aperture focusing and applied it to PA microscopy [30]. Alshaya et al.
applied DMAS to PA imaging, employing a linear array transducer and introducing a subgroup
DMAS method to improve the SNR and processing speed [31]. Matrone et al. combined filtered
DMAS (F-DMAS) with multi-line transmission to achieve high frame-rate and high resolution
[32]. Mozaffarzadeh et al. combined the minimum variance (MV) beamforming algorithm with
DMAS [33]. The MV adaptive beamformer [34] can dynamically calculate the signal weights of
the received signals instead of using a fixed apodization function. However, it is very
computationally demanding.
While all the above approaches are based on the single-stage DMAS method, Mozaffarzadeh et
al. [35] proposed a double-stage DMAS (DS-DMAS) beamforming algorithm. They literally
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divided the process of beamforming into two stages. First, the signals are processed by DMAS,
that is, the right side of the DMAS equation is expanded to the summations of the separate terms,
and these summations are treated as several new synthesized signals. Second, the new synthesized
signals are processed by the F-DMAS beamformer again to generate the final output. Same as
DMAS, DS-DMAS further improves the image resolution and reduces the side lobes, and is less
sensitive than DMAS to high noise levels at deeper depths. Since the DS-DMAS approach was
proposed, it has been adopted in photoacoustic imaging [36-38]. Very recently, Song et al.
proposed a modified version of DS-DMAS for ultrasound imaging [39]. In the first phase of
DMAS beamforming, they combined pairs of signals with the same spatial lag into a new signal.
Then they processed the new signal with F-DMAS beamforming to produce the final output. They
showed that combining the autocorrelation signals with the DMAS, the image quality of DSDMAS is slightly improved as compared with the DS-DMAS.
Several groups have proposed a nonlinear beamformer based on p-th root compression (NL-pDAS) and applied it to PA and US imaging [40-42]. The results have showed that compared with
DAS, and DMAS, the NL-p-DAS (p>2) leads to lower side lobes. However, different than DMAS
family of algorithms which is based on autocorrelation approach to improve PA and US signal
coherence, the p-th root compression may compress both signal and artifacts depending on the
relative strengths of the two parts. The p-th power applied to the coherent beam sum may or may
not compensate the signal loss depending on the constructive and destructive interferences. Thus,
the optimal choice of p-th root is tricky and highly depends on the imaging medium. Recently,
Cho el al. modified the NL-p-DAS technique and performed p-th root operation on the spectral
domain data (NL-p-SMS) instead of the temporal domain data, which could reduce the grainy
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speckles and frequency distortion caused by p-th root in temporal domain data, and dark area
artifacts [43]. The algorithm remains to be tested on more clinical data.
The coherence factor (CF) [44] is widely used for aberration correction and side lobe suppression
in PA and US imaging. Jeon et al. combined the DMAS algorithm with CF for clinical PA imaging
[45]. Mozaffarzadeh et al. combined MV with CF to achieve better resolution in PA imaging [46].
Spadin et al. compared the frequency-domain and delay-and-sum PA image reconstruction with
CF weighting [47]. Mukaddim et al. applied spatiotemporal CF to in vivo cardiac PA image
beamformation [48]. Bell et al. applied short-lag spatial coherence beamforming to cardiac
ultrasound imaging [49].
Here we propose an improved beamformer, named DMAS-LAG-CF which combines lag-based
DMAS (DMAS-LAG) [39] with CF to improve spatial resolution and image contrast for better in
vivo ovarian cancer diagnosis. To our best knowledge, this is the first time that DMAS-LAG-CF
has been implemented and applied to photoacoustic imaging, especially for clinical cancer studies.
Due to the nonlinear process of DMAS-LAG-CF, the reconstructed image intensity is not linearly
proportional to the initial PA pressure. Therefore, the typical linear unmixing method for
calculating the relative total hemoglobin concentration and oxygen saturation is not suitable.
However, the proposed DMAS-LAG-CF can achieve better image contrast using a single
wavelength in near real-time imaging.

4.2 Materials and methods
4.2.1 Proposed Reconstruction Algorithm
The improved version of DMAS [29] is formulized as
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𝒔𝒊𝒋 (𝒕) = 𝒔𝒊𝒈𝒏 (𝒔𝒊 (𝒕)𝒔𝒋 (𝒕)) . √|𝒔𝒊 (𝒕)𝒔𝒋 (𝒕)|

Eq. (5.1)

𝑵
𝒚𝑫𝑴𝑨𝑺 (𝒕) = ∑𝑵−𝟏
𝒊=𝟏 ∑𝒋=𝒊+𝟏 𝒔𝒊𝒋 (𝒕),

Eq. (5.2)

where 𝒔𝒊 and 𝒔𝒋 are the delayed signals received by the 𝒊𝒕𝒉 and 𝒋𝒕𝒉 elements, respectively. N is the
number of elements used to receive signals. 𝒚𝑫𝑴𝑨𝑺 is the DMAS beamformed output. In this
algorithm, due to the multiplication and summation, the central frequency, 𝒇𝟎 , of the original
signals is shifted to DC and 2𝒇𝟎 in the output. Thus, the output is filtered by a bandpass filter,
centered at 2𝒇𝟎 , to recover frequency components while removing DC components. Eqn. 2 can be
expanded as
𝑦𝐷𝑀𝐴𝑆 =[𝑠̅1 𝑠̅2 + 𝑠̅2 𝑠̅3 + ⋯ + 𝑠̅𝑁−2 𝑠̅𝑁−1 + 𝑠̅𝑁−1 𝑠̅𝑁 ] + [𝑠̅1 𝑠̅3 + 𝑠̅2 𝑠̅4 + ⋯ + 𝑠̅𝑁−3 𝑠̅𝑁−1 + 𝑠̅𝑁−2 𝑠̅𝑁 ] +
⋯ + [𝑠̅1 𝑠̅𝑁−1 + 𝑠̅2 𝑠̅𝑁 ] + [𝑠̅1 𝑠̅𝑁 ],

Eq. (5.3)

where 𝒔̅𝒊 = 𝒔𝒊𝒈𝒏(𝒔𝒊 )√|𝒔𝒊 | , for 𝟏 ≤ 𝐢 ≤ 𝐍. In this equation, signal pairs with the same lag are
grouped in separate brackets [39]. We consider the output of each of these brackets as a new signal
and call it 𝒔𝒔𝒊 , which is defined as
̅𝒌 ∙ 𝒔̅𝒌+𝒊 , for 𝟏 ≤ 𝐢 ≤ 𝐍 − 𝟏.
𝒔𝒔𝒊 = ∑𝑵−𝒊
𝒌=𝟏 𝒔

Eq. (5.4)

We combine each 𝒔𝒔𝒊 with the CF, and obtain a new parameter, defined as
̅̅̅𝒌 ∙ 𝒄𝒔
̅̅̅𝒌+𝒊 , for 𝟏 ≤ 𝐢 ≤ 𝐍 − 𝟏,
𝒄𝒄𝒔𝒊 = ∑𝑵−𝒊
𝒌=𝟏 𝒄𝒔
(∑𝑵 𝒔 )

Eq. (5.5)

𝟐

𝒊
̅̅̅𝒊 = 𝒔𝒊𝒈𝒏(𝒄𝒔𝒊 )√|𝒄𝒔𝒊 | . Then the final DMAS-LAG-CF can be
where 𝒄𝒔𝒊 = 𝑵 ∑𝒊=𝟏
𝑵 (𝒔 )𝟐 ∙ 𝒔𝒊 , 𝒄𝒔
𝒊=𝟏

𝒊

formulated as
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𝑵−𝟏
̅̅̅̅̅𝒊 ∙ 𝒄𝒄𝒔
̅̅̅̅̅𝒋 .
𝒚𝑫𝑴𝑨𝑺−𝑳𝑨𝑮−𝑪𝑭 = ∑𝑵−𝟐
𝒊=𝟏 ∑𝒋=𝒊+𝟏 𝒄𝒄𝒔

Eq. (5.6)

The schematic diagram of DMAS-LAG-CF is shown in Figure 4.1. All the symbols used in the
diagram are the same as those in the Eq. 5.5 and 5.6. This diagram depicts how to synthesize new
signals in terms of different lags which are discriminated by different colors in Figure 4.1. To
compare the performance of DMAS-LAG-CF with DMAS-CF, we also implemented the DMASCF algorithm which is formulized as

𝑵
𝒚𝑫𝑴𝑨𝑺−𝑪𝑭 = ∑𝑵−𝟏
𝒊=𝟏 ∑𝒋=𝒊+𝟏 𝒔𝒊𝒈𝒏(𝒄𝒔𝒊 ∙ 𝒄𝒔𝒋 ). √|𝒄𝒔𝒊 𝒄𝒔𝒋 |.

Figure 4.1: Schematic diagram of DMAS-LAG-CF.
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Eq. (5.7)

4.2.2 Co-registered PAT/US Imaging System
Our co-registered PAT/US imaging system, described in detail in [10, 50], consists of a Ti:
sapphire (Symphotics TII, LS-2122) optically pumped with a Q-switched Nd: YAG laser
(Symphotics TII, LS-2134) to deliver pulsed laser light (10 – 30 ns pulse duration, 15 Hz pulse
repetition rate), a commercial ultrasound system (EC-12R, Alpinion Medical Systems), and a 128
channel curved transvaginal ultrasound transducer (central frequency: 6 MHz, 80% bandwidth).
For each imaging position, the system is programmed to record data sequentially at wavelengths
of 730, 780, 800, and 830 nm. The pulsed laser light output at tissue surface is below the ANSI
safety limit [51]. Note that, due to the nonlinear process of DMAS-LAG-CF, we use only a single
wavelength (730 nm) for the following data processing.

4.2.3 Ovarian Cancer Patients
A total of 28 patients enrolled from May 2017 to November 2018, were evaluated in this study.
Among these patients, both ovaries were imaged in 12 patients; for the remaining 16 patients, only
one suspicious ovary with pathological evaluation was imaged. Among 40 ovaries, 10 had invasive
serous or endometroid ovarian cancer, one had a serous borderline tumor, and the rest were
benign/normal ovaries. The borderline tumor was included in the cancerous group in the analysis.
This study protocol was approved by the Institution Review Board of Washington University
Medical School in St. Louis and all patients signed the informed consent.

4.2.4 Feature Selection and Classification
Histograms of PAT image envelopes were computed from the malignant and benign/normal
groups, and three features--variance, skewness, and kurtosis, (see Appendix A)--were extracted
quantitatively from the histograms to characterize these two groups. The mean values of PAT
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image envelopes (PAT_mean) within the regions of interest (ROIs) and the corresponding
histogram features were tested using two-sample two-sided Student’s t tests. A feature with a pvalue equal to or less than 0.05 (p ≤ 0.05) was considered significant.
Next, we performed a regression analysis on our data to find the best logistic regression model.
Models were developed for three sets of independent features extracted from all the patients:
PAT_mean alone, PAT_mean and kurtosis combined, and PAT_mean and skewness. Skewness
and kurtosis were not evaluated as a set because they are highly correlated by Spearman’s cross
correlation. For each model, the receiver operating characteristic (ROC) curve and the area under
the curve (AUC) were calculated, and the best model was determined by the highest AUC value.

4.2.5 Performance Evaluation
First, we compared the spatial resolution and side lobe performance of the DAS, DMAS, DMASCF, DMAS-LAG, and DMAS-LAG-CF beamforming algorithms, using a simulated numerical
phantom. The raw data consisted of seven equidistant pairs of point targets located at seven
different depths. The transducer array geometry used in the simulation was linear, with 64 elements
(element pitch, 231 μm; kerf, 38.5 μm; element height and width, 14 mm and 192.5 μm; lambda,
385 μm). The full width at half maximum (FWHM) was calculated from the fitted Gaussian curve
after deconvolution with the transfer function of the transducer, and this value is used as a measure
of the spatial resolution throughout the paper. We compared the performance of DAS, DMAS,
DMAS-CF, DMAS-LAG, and DMAS-LAG-CF by imaging a 200 μm diameter black thread
perpendicular to the imaging plane and submerged in a water tank filled with calibrated intralipid
solution (Fresenius Kabi, USA) with a reduced scattering coefficient (𝛍′𝐬 ) of 4 𝐜𝐦−𝟏 and an
absorption coefficient (𝛍𝐚 ) of 0.02 𝐜𝐦−𝟏 .
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Next, we compared the contrast ratios (CRs) of a simulated contrast phantom as reconstructed by
the DAS, DMAS, DMAS-CF, DMAS-LAG, and DMAS-LAG-CF beamforming algorithms.
Following the same procedure as in [52, 53], we modeled a benign cyst as a 15-mm-diameter
sphere within a tissue mimicking medium (the cube size was 84 * 84 * 70 mm) at a depth of 20
mm. The tissue mimicking background medium’s 𝝁𝒂 was set as 0.1 𝐜𝐦−𝟏 , and 𝝁′𝒔 was set as 5
𝐜𝐦−𝟏 . As the positive contrast (higher than the background 𝝁𝒂 ), the cyst’s 𝝁𝒂 was set as 0.9 𝐜𝐦−𝟏
and 𝝁′𝒔 was set as 0.0001 𝐜𝐦−𝟏 to mimic an aqueous medium without scattering. The CR index is
defined as CR = 𝟐𝟎 𝐥𝐨𝐠 𝟏𝟎 𝑰𝒕𝒂𝒓𝒈𝒆𝒕 /𝑰𝒃𝒂𝒄𝒌𝒈𝒓𝒐𝒖𝒏𝒅 , where 𝑰𝒕𝒂𝒓𝒈𝒆𝒕 and 𝑰𝒃𝒂𝒄𝒌𝒈𝒓𝒐𝒖𝒏𝒅 are the PAT_mean
in the target and background areas. The ideal CR based on 𝝁𝒂 ratio is 19dB.
We then applied the DAS, DMAS, DMAS-CF, DMAS-LAG, DMAS-LAG-CF algorithms to
ovarian cancer patient data to improve the image contrast between the PAT image envelopes of
the cancerous masses and those of the benign/normal lesions. We calculated the PAT_mean in
each ROI and extracted the histogram features from the corresponding PAT image envelopes.
Ultrasound images were employed to select an ROI corresponding to the lesion. Note that we
selected only one normal or cancer area for each ovary. Thus, a total of 11 cancer areas and 29
normal areas were obtained for quantitative feature extraction and classification.

4.3 Results
As shown in Figure 4.2 (a), the simulated point target pairs reconstructed by DMAS-LAG-CF are
smaller than those reconstructed by the other algorithms. Based on the 1-D profile from DMASLAG-CF in Figure 4.2 (b), the two peaks corresponding to the two point targets are sharpest and
the side lobes are lowest. Also, from the lateral resolution calculated at three different depths (49,
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59, 69 mm) shown in Figure 4.2 (c), the lateral resolution for DMAS-LAG-CF is around 1.70,
1.52, 1.10, and 1.20 times better than the values for DAS, DMAS, DMAS-CF and DMAS-LAG.
In Figure 4.3, the black thread cross-section reconstructed by DMAS-LAG-CF is thinnest. Based
on 1-D profiles across the black thread, the lateral resolution of DMAS-LAG-CF is respectively
around 1.39, 1.30, 1.07, and 1.15 times better than those of DAS, DMAS, DMAS-CF, and DMASLAG. The theoretical value of the spatial resolution is around 0.20 mm.
The geometry of the simulated contrast phantom is shown in Figure 4.4 (a). We selected two
background areas for fair judgement (the dashed square marked as 2 and 3 in Figure 4.4 (b), Figure
4.4 (c), Figure 4.4 (d), Figure 4.4 (e), and Figure 4.4 (f)), with corresponding contrast ratios of
CR1 and CR2. Comparing Figure 4.4 (b), Figure 4.4 (c), Figure 4.4 (d), Figure 4.4 (e), and Figure
4.4 (f), we can see that the image reconstructed by DMAS-LAG-CF has the best contrast between
the target and background area. Quantitatively, the CR1 of DMAS-LAG-CF was around 12.19 dB,
8.81 dB, 7.47 dB, and 4.10 dB higher than those of DAS, DMAS, DMAS-CF, and DMAS-LAG,
based on the mean values of the image intensity calculated in the target and background areas.
Also the CR2 of DMAS-LAG-CF was around 9.35 dB, 6.83 dB, 5.85 dB, and 2.96 dB higher than
those of DAS, DMAS, DMAS-CF, and DMAS-LAG. On average, the CR of DMAS-LAG-CF was
around 10.77 dB, 7.82 dB, 6.66 dB, and 3.53 dB higher than those of DAS, DMAS, DMAS-CF,
and DMAS-LAG. In Figure 4.4 (c), Figure 4.4 (d), Figure 4.4 (e), and Figure 4.4 (f), one small dot
appears underneath the chosen target area because the scattering coefficient of the cyst target is
very low, and a small portion of light propagates through the target area with higher light fluence
than background to illuminate the region underneath. Also, one red area appears right on top of
the chosen target area close to the transducer face, because the light has traveled only a very short
distance and has not yet been fully diffused.
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Figure 4.2: (a) Simulated point target pairs reconstructed by DAS, DMAS, DMAS-CF, DMASLAG, and DMAS-LAG-CF (dynamic range, 15 dB). (b) The corresponding 1-D profiles of the
images in (a) at a depth of 49 mm. (c) The lateral resolution performance for DAS, DMAS, DMASCF, DMAS-LAG, and DMAS-LAG-CF at depths of 49 mm, 59 mm, and 69 mm.
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Figure 4.3: (a) Black thread images reconstructed by the DAS, DMAS, DMAS-CF, DMAS-LAG,
and DMAS-LAG-CF algorithms (dynamic range, 10 dB; scale, cm). (b) The corresponding 1-D
profiles across the black thread (averaged from 20 consecutive envelopes along the depth). (c)
Calculated spatial resolution results based on the 1-D profiles across the black thread.
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Figure 4.4: (a) Phantom geometries used for simulations. Simulated contrast phantom images
reconstructed by the DAS (b), DMAS (c), DMAS-CF (d), DMAS-LAG (e), and the DMAS-LAGCF (f) algorithms (dynamic range, 10 dB; scale bar, cm). (e) Calculated CR results based on the
mean values of the image intensity in the target and background areas (target areas: dashed square
areas 1 of (b), (c), (d), (e), and (f); background areas: dashed square areas 2 and 3 of (b), (c), (d),
(e), and (f)). CR1 and CR2 correspond to the dashed square areas 2 and 3.

90

91

Figure 4.5: PAT images (730 nm) and corresponding histogram features extracted from an ovarian
cancer (a)-(j) and a benign ovary (k)-(t). All PAT images are displayed with 15dB dynamic range.

Figure 4.6: (a)-(c): Boxplots of mean values of PAT envelopes using (a) DAS, (b) DMAS (left)
and DMAS-CF (right), and (c) DMAS-LAG (left) and DMAS-LAG-CF (right). (d)-(f): Boxplots
of kurtosis using (d) DAS, (e) DMAS (left) and DMAS-CF (right), and (f) DMAS-LAG (left) and
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DMAS-LAG-CF (right). (g)-(i): Boxplots of skewness using (g) DAS, (h) DMAS (left) and
DMAS-CF (right), and (i) DMAS-LAG (left) and DMAS-LAG-CF (right). The p-value is shown
in the associated plot. The number of samples in each group is also shown in the x-axis of each
plot.

Figure 4.7: ROC curves and associated AUC values of five regression models developed to fit the
data extracted from all patients. Regression model of DAS (a), DMAS (b), DMAS-CF (c), DMASLAG (d), and DMAS-LAG-CF (e).

Figure 4.5 shows one example PAT image (730 nm) from an ovarian cancer, calculated by DAS,
DMAS, DMAS-CF, DMAS-LAG, and DMAS-LAG-CF. The CRs were computed from the two
background regions and the target central region as marked by the white boxes in the images. The
average CRs computed from the two background regions were given in the table. For the cancer
case, the DMAS-LAG-CF improved CR of DAS, DMAS, DMAS-CF and DMAS-LAG by 6.9 dB,
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5.1 dB, 2.5dB and 1.2 dB, respectively. For the benign case, the corresponding improvements of
CR were 7.6 dB, 4.6 dB, 3.4 dB, 1.5 dB, respectively. Thus, DMAS-LAG-CF performs the best
on improving CR. However, since the clinical significance is the diagnostic accuracy between
cancer and benign/normal ovarian lesions, we have evaluated PAT-mean ratios of the two
examples. The PAT-mean ratios of the cancer to benign lesions are 2.32, 2.21, 2.16, 2.11, and
2.03 for DMAS-LAG-CF, DMAS-LAG, DMAS-CF, DMAS, and DAS, respectively. DMASLAG-CF improves PAT-mean ratio by 5%, 7%, 10% and 14% compared with DMAS-LAG,
DMAS-CF, DMAS, and DAS.
Figure 4.6 shows boxplots for the PAT_mean and histogram features (kurtosis, skewness), across
the entire set of 28 patients between the benign/normal and cancer areas for DAS, DMAS, DMASCF, DMAS-LAG, and DMAS-LAG-CF. The variance feature, not shown here, is not significant
for all five algorithms. The number n in the plots corresponds to the total number of areas. In terms
of three extracted histogram features (PAT-mean, kurtosis, and skewness), the p values between
cancers and benign/normal lesions obtained from DMAS-LAG and DMAS-LAG-CF were lower
than those of the standard DAS beamforming algorithm.
Figure 4.7 shows the ROC curves and AUC values of the fitting data sets, using regression models
for DAS (Figure 4.7 (a)), DMAS (Figure 4.7 (b)), DMAS-CF (Figure 4.7 (c)), DMAS-LAG
(Figure 4.7 (d)), and DMAS-LAG-CF (Figure 4.7 (e)). When skewness and PAT_mean are
included in the feature set, the best performances (the highest AUC values for the data set) are
0.87, 0.86, 0.82, 0.89, and 0.91 for DAS, DMAS, DMAS-CF, DMAS-LAG, and DMAS-LAGCF, respectively.
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4.4 Discussion and Summary
In this paper, we implemented an improved beamformer, named DMAS-LAG-CF, which
combines lag-based delay multiply and sum with coherence factor.
We first compared the spatial resolution and contrast performance of the DAS, DMAS, DMASCF, DMAS-LAG, and DMAS-LAG-CF beamforming algorithms using a simulated numerical
phantom. Compared to the performances of DAS, DMAS, DMAS-CF, and DMAS-LAG, the
lateral resolution for DMAS-LAG-CF was around 1.70, 1.52, 1.10, 1.20 times better. Then we
imaged a 200 μm diameter black thread perpendicular to the imaging plane and submerged in a
water tank filled with calibrated intralipid solution and found that the lateral resolution of DMASLAG-CF was around 1.39, 1.30, 1.07, 1.15 times better than those of DAS, DMAS, DMAS-CF,
and DMAS-LAG. Afterwards, we compared the CR performance of DAS, DMAS, DMAS-CF,
and DMAS-LAG, and DMAS-LAG-CF using a simulated contrast phantom. On average, the CR
for DMAS-LAG-CF was around 10.77 dB, 7.82 dB, 6.66 dB, and 3.53 dB higher than those of
DAS, DMAS, DMAS-CF, and DMAS-LAG. Thus, the improvement of DMAS-LAG-CF over
other algorithms is in image contrast. The two clinical examples have demonstrated similar
improvement in computed CRs. The corresponding CRs for the cancer case were 6.9dB, 5.1dB,
2.5dB and 1.2 dB, and CRs for the benign case were 7.6, 4.6,3.4 and 1.5dB.
Since the clinical value of diagnostic accuracy is between cancer and benign/normal lesions, we
applied the DMAS-LAG algorithm without and with the coherence factor, to patient data to
enhance the contrast between PAT images of cancerous masses and that of benign/normal ovarian
lesions. In terms of three extracted histogram features (PAT_mean, kurtosis, and skewness), the p
values between cancers and benign/normal lesions were lower than those of the standard DAS
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beamforming algorithm. The best DMAS-LAG-CF regression model achieved an AUC of 0.91,
when PAT_mean and skewness were included in the feature set. This is significant in offering
diagnosis to patients using photoacoustic imaging co-registered with ultrasound.
The three PAT features are related to the distribution of absorbers inside the ovaries. For
example, a cancerous ovary has large clusters of highly absorbing micro-vessels, and it is expected
that its PAT histogram should be more skewed towards higher mean values. DMAS-LAG and
DMAS-LAG-CF improve PA signal coherence over DAS, and thus these algorithms enhance the
contrast between highly absorbing cancerous tissue and benign/normal lesions. Kurtosis measures
how close the distribution’s tail is to the tail of a normal distribution. If there are many outliers in
the histogram, the distribution is heavily tailed. Therefore, kurtosis can be a good measure of the
number of absorbers that are considered as outliers. Again, DMAS-LAG and DMAS-LAG-CF
improve PA signal coherence and therefore increase the deviation of cancerous tissue, with large
clusters of highly absorbing micro-vessels, from that of a normal distribution.
DMAS-LAG [39] is essentially the same as the DS-DMAS which improves DMAS by improving
off-axis noise levels at deeper depths [35]. Thus, the contrast improvements of DMAS-LAG over
DMAS and DMAS-LAG-CF over DMAS-CF are expected. However, both DMAS and DMASCF should also improve the diagnostic performance of DAS because they both improve PAT signal
coherence by reducing off-axis noise. Only PAT_mean computed from DMAS between cancer
and benign/normal groups has a lower p value than that of DAS. We were supervised that the ROC
analysis of patient data did not show improvement of DMAS and DMAS-CF over DAS, which
warrants further investigation.
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Note that, compared with the computational complexity of DAS (O(N), where N is the number of
elements), DMAS-LAG-CF has an exponentially higher computational complexity (O(N2)). Also,
the bandpass filters involved in the post-processing of the DMAS-LAG-CF rely on two
computationally intensive Fourier transforms. In processing a single frame from a patient dataset,
the average runtime of our DMAS-LAG-CF algorithm was about 10 times longer than that of
DAS. The reconstruction was performed by running MATLAB R2018 on a Windows 10 operating
system using an i3-6100 CPU (Intel, Santa Clara, CA, USA) and 16 GB memory. To achieve near
real-time clinical application, the processing speed can be improved with a better computational
platform and GPU processing. Also, the two-stage signum, absolute, and square root operations
slowed down DMAS-LAG-CF. In some application situations, we can perform only one stage of
the above operations to improve the processing speed at the expense of slightly lower resolution
and higher side lobes. Moreover, we can reduce the lag number for combinational multiplication
in the second stage to improve the processing speed at the cost of a decreased effective aperture
(spatial resolution).
Overall, this initial study shows that the proposed beamforming algorithm can achieve valuably
better image contrast for improved diagnosis of ovarian cancer with a cohort of 28 patients.
DMAS and DMAS-LAG are nonlinear beamformers and the linear unmixing method to compute
the relative hemoglobin contrast from multi-wavelength data cannot be implemented directly. This
is an inherent limitation of DMAS based beamforming methods. However, the methods can be
readily implemented in single wavelength PA imaging for near real time ovarian cancer diagnosis
as well as other oncology applications.
Appendix A: Histogram features extraction
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The three histogram features can be computed from Eq. (5.8) to (5.10), where 𝑥𝑖 is the pixel gray
level and N is the total number of pixels.
1

2
Variance (𝜎 2 ) = 𝑁 ∑𝑁
𝑖=1(𝑥𝑖 − 𝜇)

Skewness =

1
𝑁

∑𝑁
𝑖=1 [

1

Kurtosis = 𝑁 ∑𝑁
𝑖=1 [
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Chapter 5: Assess human colorectal cancer,
using a co-registered photoacoustic and
ultrasound tomography system
5.1 Introduction
Photoacoustic imaging (PAI) is an emerging technique which can provide high optical absorption
contrast images at reasonable microscale resolution and clinically relevant depths [1]. Several
studies have established that optical absorption parameters are important biomarkers directly
related to the tissue microvasculature, tumor angiogenesis or tumor hypoxia [2-4]. In general, PAI
is classified into photoacoustic microscopy (PAM) and photoacoustic tomography (PAT) [1].
Previously, PAM or Photoacoustic endoscopy (PAE) have demonstrated the capability of detecting
human colorectal cancer [5-6]. However, the low imaging speed (limited by the laser repetition
rate and scanning scheme), small imaging area, and shallow penetration depth (<7 mm) created
obstacles for clinical applications.
Compared with PAM, PAT is able to penetrate deeper with a faster data acquisition speed and a
larger field of view due to the use of ultrasonic arrays and a wide optical beam. Several studies
have demonstrated that PAT/US dual-modality imaging system can provide anatomical and
functional information in tumors [7-13], but no prior applications in the human distal GI tract have
been reported using PAT/US dual-modality imaging.
Adenocarcinoma of the colon and rectum is the second most common malignancy diagnosed
globally and the 4th leading cause of cancer mortality, with more than 100,000 new cases diagnosed
annually in the US [14-15]. Accurate staging and post-treatment surveillance of this prevalent
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disease are critical because treatment strategies are predicated upon the stage at presentation and
response to therapy – in some instances, detailed imaging allows certain patients to avoid surgery
altogether. While colonoscopy and biopsy are the gold-standard diagnostic tests for colorectal
cancers [16], multiple imaging modalities including optical imaging [17-18], endoscopic
ultrasound (EUS), pelvic magnetic resonance imaging (MRI), computed tomography (CT) and
positron emission tomography (PET) are also utilized.
Unfortunately, each of these modalities have critical weaknesses when evaluating colorectal
tumors. White light endoscopy (WLE) only detects macroscopic morphology and provides no
functional assessment of the imaged tissue. MRI has limited between-slice resolution and is often
unable to differentiate early tumors from benign neoplasia, committing patients to potentially more
invasive treatment regimens than needed [19-20]. Monitoring of tumors after chemotherapy and
radiation with MRI is often confounded by fibrotic reaction and edema, which can appear similar
to residual tumor [21]. CT has poorer resolution of the bowel wall layers in comparison to MRI,
subsequently limiting its ability to describe circumferential resection margin (CRM) status or
serosal invasion in locally advanced cases. Additionally, CT also cannot distinguish induration or
peritumoral fibrosis from frank malignant disease with a high degree of specificity, further limiting
its application in local tumor staging [19]. PET imaging is also plagued by poor resolution, and
EUS remains highly user-dependent and unable to resolve small islands of tumor [19]. Therefore,
critical need exists for precise imaging modalities of colorectal tumors for both staging and
therapeutic response evaluations.
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PAT, in contrast, uniquely provides functional imaging at high resolution by using hemoglobin as
an endogenous contrast agent. By detecting the abnormal vasculature that accompanies colorectal
malignancies, we hypothesized that this modality might be able to identify malignant or residual
tumors otherwise undetectable by current clinical imaging. We therefore performed the following
pilot study to test a real-time co-registered PAT/US system prototype and assess its ability to
delineate differences between benign and malignant tissue. To the best of our knowledge, this
study is the first utilizing co-registered PAT/US to evaluate human colon samples.

5.2 Methods
5.2.1 Human Sample Preparation
Freshly resected colon and rectum samples obtained from patients undergoing surgery at
Washington University School of Medicine were imaged immediately after surgery. Patients with
known benign neoplasia (polyps) as well as malignancies (adenocarcinoma) were eligible for
imaging. Cancer patients who had received preoperative treatment with chemotherapy and /or
radiation were also included. The study was approved by the Institutional Review Board (IRB) at
Washington University (#201707066). Informed consent was obtained from all patients.
Specimens were obtained from the operating room as previously described [6].
A total of 23 tissue samples were imaged in the pilot study using the PAT/US system. This included
untreated colorectal adenocarcinomas (n=12), precancerous polyps (n=6), colorectal cancer
following chemotherapy or radiation and chemotherapy (n=4), and post polypectomy (n=1). Two
treated patients have achieved complete pathological response and two partial response. The
majority of patients underwent hemicolectomy for cancer and were found to have malignancy on
histologic analysis (Table 5.1).
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Table 5.1: Summary of Specimens
Patient
ID

Surgery

1
2
3
4

Total colectomy
Right Hemicolectomy
Right Hemicolectomy
Sigmoid colectomy

5
6

Right Hemicolectomy
Low anterior resection

7
8

Left colectomy
Low anterior resection

9
10
11
12
13
14
15
16

Low anterior resection
Right hemicolectomy
Right hemicolectomy
Right hemicolectomy
Right hemicolectomy
Left colectomy
Left Hemicolectomy
Low anterior resection

17
18
19

Sigmoidectomy
Transverse colectomy
Low anterior resection

20
21

Low anterior resection
Total colectomy

22
23

Right hemicolectomy
Right hemicolectomy

Pathology
Moderately differentiated adenocarcinoma (T3)
Tubular adenoma (precancerous polyp)
Moderately differentiated adenocarcinoma (T2)
Treated moderately differentiated adenocarcinoma
(T3); post chemotherapy
Tubular adenoma (precancerous polyp)
Complete pathologic response-no residual tumor
after radiation and chemotherapy
Moderately differentiated adenocarcinoma (T2)
Complete pathologic response-no residual tumor
following radiation and chemotherapy
Tubulovillous adenoma (precancerous polyp)
Moderately differentiated adenocarcinoma (T3)
Moderately differentiated adenocarcinoma (T2)
Moderately differentiated adenocarcinoma (T4)
Tubular adenoma (precancerous polyp)
Moderately differentiated adenocarcinoma (T4)
Tubulovillous adenoma (precancerous polyp)
No residual tumor following prior polypectomy*
Moderately differentiated adenocarcinoma (T3)
Moderately differentiated adenocarcinoma (T2)
Treated moderately differentiated adenocarcinoma
(T3); post radiation and chemotherapy
Moderately differentiated adenocarcinoma (T3)
Moderately to poorly differentiated adenocarcinoma
(T3)
Moderately differentiated adenocarcinoma (T3)
Differentiated adenocarcinoma (mixed polyp and
adenocarcinoma)

Note: T is the primary tumor depth of invasion, per TNM guidelines.
* No residual tumor was found after polypectomy. We have grouped this case with the complete
responders.

5.2.2 Co-registered Ultrasound-guided Photoacoustic Tomography System
As shown in Figure 5.1, the system [11, 22] consists of three main parts: a Ti:sapphire laser
(Symphotics TII, LS-2134, Symphotics, Camarillo, California) optically pumped with a Qswitched Nd:YAG laser (Symphotics TII, LS-2122), an optimized optical fiber-based light
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delivery system [23], and a commercial US system (EC-12R, Alpinion Medical System, Republic
of Korea) used for acquiring the corresponding US and PAT data. With this system, pulsed laser
light (pulse duration: 10 ns, pulse repetition rate: 15Hz, 20 mJ/pulse at 750 nm wavelength) was
delivered to tissue placed on a 2D motorized scanning stage. B-scan images were acquired for
four wavelengths (730, 780, 800, 830 nm) at each area of imaged tissue among the 23 specimens.
The overall scanning area varied from 1 to 3 cm, while image acquisition time for a region of
interest (ROI) was 12-15 seconds with a frame rate of 15 frames per second. Care was taken to
acquire images from abnormal tissues as well as corresponding normal areas, as marked by a
trained pathologist.

Figure 5.1: Schematic diagram of co-registered ultrasound-guided photoacoustic tomography
system.
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5.2.3 Extraction of Functional, Spectral, and Textural features
Several functional, spectral, and textural features were extracted from the PAT and US data and
images as given in Table 5.2.
Table 5.2: Abbreviations
Abbreviation
rHbT
SS (PAT)
0.5MHz SI (PAT)
MBF (PAT)
SS (US)
0.5MHz SI (US)
MBF (US)
Sig_rad
Homogeneity
Energy
Contrast
Correlation

Description
relative total hemoglobin
mean PAT spectral slope
0.5 MHz spectral intercept from PAT spectra
mid-band fit from PAT spectra
mean US spectral slope
0.5 MHz spectral intercept from US spectra
mid-band fit from US spectra
standard deviation of the mean radon transform
the homogeneity of image textures
the grayscale distribution homogeneity of images and
texture crudeness
the sharpness of images and the depth of texture
grooves
the consistency of image texture

Functional features
The relative oxy-hemoglobin (rHbO2) and deoxy-hemoglobin (rHb) at each pixel can be calculated
using the following equations:
𝑟𝐻𝑏𝑂2 (𝑟, 𝛳) = 𝐶(𝑟, 𝛳)𝐻𝑏𝑂2 (𝑟, 𝛳)

Eq. (5.1)

𝑟𝐻𝑏(𝑟, 𝛳) = 𝐶(𝑟, 𝛳)𝐻𝑏(𝑟, 𝛳),

Eq. (5.2)

where 𝐶(𝑟, 𝛳)=𝛤𝐶0 (𝑟, 𝛳)Ø(𝑟, 𝛳) , Γ is the tissue’s Grüneisen parameter, 𝐶0 (𝑟, 𝛳) is the system
acoustic operator, Ø(𝑟, 𝛳) is the local fluence which can be approximated as wavelength
independent at the narrow wavelength window we have used. Based on these equations, deriving
rHbO2 and rHb requires a known tissue fluence distribution. Since this distribution is difficult to
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determine in human tissue due to wide variation in composition, we computed relative rHbO2 and
rHb values instead. By summing the rHbO2 and rHb at each pixel, the relative total hemoglobin
(rHbT) for each pixel is computed; the average rHbT for a ROI was then calculated by averaging
the rHbTs of all pixels in that ROI with a value at least half of the maximum rHbT. All PAT images
in the co-registered US and PAT images were rHbT without any normalization.
Spectral features
Ultrasound images were employed to select a proper ROI corresponding to the lesion for PAT
spectral feature calculations [9, 24]. First, PAT beam lines with a maximum value close to the
background noise level of our co-registered US/PAT system (60 mV) were ignored. The rest of
the beam lines were gated by a hamming window, and then their FFT in -10dB frequency range
were calculated. Moreover, to cancel the frequency response of the transducer and electrical
receiving system [24], the spectra of PAT beams were normalized to the spectra of an approximate
point-like target (a 250-μm black thread orthogonal to PAT imaging place with a varied distance
to transducer from 0.5 cm to 7 cm and a step of 0.25 cm).
After calibrating our data, each of the calibrated PAT spectra was fitted linearly. The mean spectral
slope (SS), midband fit (MBF), and 0.5 MHz spectral intercept (0.5 MHz SI (PAT)) were then
calculated (Figure 5.2). We chose 0.5 MHz spectral intercept as a feature instead of 0 MHz because
the lower bound of our transducer in PAT mode is approximately 0.5 MHz.
US spectral features were also calculated. To do this, similar method as PAT spectral features
extraction was followed. The only differences were: first, the analysis was performed in the
frequency range of 3.5 to 7 MHz, which is the -10dB frequency range of the transducer in US
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mode. Second, the calibration was performed using a reference gelatin-based phantom constructed
in our lab [25].
PAT image features

After visual inspection of PAT frames of malignant and normal colon samples, we noticed that the
textures of these images looked different between the two types of samples. To confirm our
observation, we extracted PAT image features from available image frames. To do so, a proper
ROI was first chosen. To find the center of this ROI, the region surrounding the lesion was
determined based on the US image, and the Radon transforms at the two angles of 0 and 90 degrees
of the PAT image in this region were calculated. Each of these Radon transforms was then
normalized to its own maximum values and a Gaussian curve was fitted to each of them. The center
of the square ROI where the image analysis was performed was determined by the means of these
two Gaussian curves and its size was assumed to be 1 cm for all cases (Figure 5.3).
Textural features of the normalized PAT images were calculated in the specified ROI [24]. The
first step in calculating these features is to construct a gray-level co-occurrence matrix (GLCM)
[26]. GLCM quantifies how the pixels are connected in the image. The size of this matrix was
chosen as 16*16 pixels. The value of pixel (i,j) of this matrix was chosen to be the number of
times that gray levels i and j are adjacent to each other in the PAT image. Note that we assumed
that the two gray levels g1 and g2 are adjacent if g1 is positioned at the immediate left of g2. After
constructing the GLCM matrix, four textural features were calculated for each PAT image frame
using the following equations:

Contrast 
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N
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 | i  j |  c(i, j)
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Eq. (5.3)
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Eq. (5.6)

where c(i,j) is the value of the (i,j) pixel of the GLCM, N is the dimension of this matrix, and σ
and µ are the standard deviation and mean for row i or column j of the GLCM.
The standard deviation of the mean radon transform (Sig_rad) was the last image feature that was
calculated in this study. To calculate this feature, the radon transform of the non-normalized PAT
image at angles 0 to 90 degrees with a step of 1 degree were calculated and an average was taken
over these transforms. Then a Gaussian curve was fitted to this mean radon transform and the
standard deviation of this curve was measured.
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Figure 5.2: Top row: co-registered rHbT and US images of a cancerous (left) and a normal (right)
colon sample. Bottom row: the calibrated PAT power spectra along with their fitted lines in the
regions marked with the angular dashed lines in each image.
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Figure 5.3: ROI selection for image analysis. The region covering the lesion is determined (left),
and the normalized Radon transforms at 0 and 90 degrees are calculated. A Gaussian curve is then
fitted to each Radon transform. The center of the square ROI where the image analysis is
performed is determined by the means of these two Gaussian curves and its size is 1 cm.

5.2.4 Feature Selection and Classification
A two-step approach was used to select features most likely to differentiate normal from untreated
malignant tissue. In the first step, all previously discussed PAT/US features were tested in
univariate analysis between untreated cancer and normal regions, and p values were generated by
two-sample two-sided Student’s t tests. The features where p > 0.05 – which we concluded a priori
not to be significantly associated with malignancy – were excluded from the classification model
(Table 5.3).
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Table 5.3: Significance testing of individual covariates as related to tissue diagnosis
Feature
rHbT
SS (PAT)
0.5 MHz SI (PAT)
0.5 MHz SI (US)
Homogeneity
Energy
Sig_rad
MBF (PAT)
MBF (US)
SS (US)

p-value
<0.001
<0.001
0.002
0.01
0.01
0.02
0.03
0.12
0.23
0.55

Next, logistic a general logistic mode (GLM) and a support vector machine (SVM) were used to
evaluate the strength of association of each feature with the ultimate tissue diagnosis, and a
prediction model was then constructed with significant covariates. In total, 18 areas selected from
18 specimens and 12 malignant areas from 12 untreated cancer specimens were used to construct
and evaluate the prediction models. Out of these, 12 normal and 8 malignant areas were used for
prediction model derivation and the rest (6 normal and 4 malignant areas) for internal model
validation. The receiver operating curve (ROC) and the area under the curve (AUC) were used to
evaluate the accuracy of the model. Finally, a second prediction model was constructed without
rHbT to determine how limiting the PAT/US device to a single wavelength would affect
identification of malignancies.

5.3 Results
5.3.1 Qualitative Analysis: Baseline Characteristics of US and PAT Images
Colorectal tissues are composed primarily of fluid, lipid, collagen, and muscle. The general
architecture (from superficial to deep) in a normal specimen is mucosa (fluid-filled cells
surrounded by lipid bilayers), submucosa (largely composed of extracellular collagen matrix and
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some muscle fibers), muscularis propria (muscle), and adipose tissue (lipid). In malignancy, the
individual cell types are similar but the architecture is distorted because cancerous cells of mucosal
origin penetrate into the deeper layers of the organ. As these cells invade, the organized structure
of the tissue is lost.
Figure 5.4 shows specimen photographs, US images, and co-registered PAT/US rHbT maps as
well as histologic images from a representative region of normal colon samples (5.4 a - 5.4 d), and
a colorectal malignancy (5.4 e - 5.4 h). The white arrows indicate the scanning direction along
which B-scans were recorded at four different wavelengths (the imaging plane is perpendicular to
the scanning direction). In the standalone ultrasound images, the normal layered structure of the
colorectal wall is clearly delineated (5.4 b). In the presence of malignancy, however, this organized
structure is distorted by the tumor and loses the clear delineation of mucosal, submucosal, and
muscular layers. These findings mirror the differences in histology among the specimens; in
contrast to the ordered layering of the normal colonic wall (images 5.4 d), the tumors appear
disorganized with destruction of the underlying colonic architecture (images 5.4 h).
Additionally, the rHbT maps computed from coregistered PAT/US images of benign regions show
significantly lower rHbT signals (5.4 c) than maps from the malignant lesions (5.4 g). As
demonstrated in these representative images, normal tissue was found to have almost no detectable
rHbT signal. In contrast, malignant tissue showed much higher concentrations of hemoglobin
around the tumor bed. Again, these findings appear corroborated by histologic examination. In
comparison to the relative paucity of large blood vessels in normal tissue, the malignancies were
more vascular and contained large blood vessels (red arrows in images 5.4 h).
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It is interesting to note that fatty tissues have limited PAT signals in the outer portions of the
specimens. This is not surprising since we are specifically targeting hemoglobin – which is not
concentrated in fatty tissue – as our chromophore of interest, and therefore we image within the
730-830 nm wavelength range. Additionally, all PAT images are displayed with the same dynamic
range of -10 dB, so anything below this level is not displayed. The fatty tissue, due to its lack of
vascular structures, falls below this range.

Figure 5.4: Color photograph, US image, rHbT map, and H&E image from representative areas of
(a)-(d) a normal region and (e)-(h) a malignant region of pretreatment colorectal cancer tissue. Red
arrows identify blood vessels within the histologic images.
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Figure 5.5: Color photograph, US image, rHbT map, and H&E image from representative areas of
(a)-(d), a pretreatment colorectal cancer, (e)-(h) a post-treatment colorectal cancer tissue with
residual disease, and (i)-(l) a post-treatment colorectal cancer tissue without residual disease.

5.3.2 Evaluation of Treated Tumors
Figure 5.5 shows corresponding images from a representative untreated colon cancer sample (5.5
a - 5.5 d), a colon tumor treated with preoperative chemotherapy (5.5 e – 5.5 h), and a rectal
malignancy that received radiation and chemotherapy prior to surgical resection (5.5 i - 5.5 l). The
untreated tumor displays findings consistent with other untreated colorectal cancers: loss of
layered wall structure, increase in rHbT signal, and increased vascularity throughout the tumor
bed. However, treatment appears to reverse these changes. For example, the PAT signal appears
to diminish with chemotherapy (5.5 g) and even disappear altogether with complete destruction of
the tumor (5.5 k). Additionally, ultrasound imaging demonstrates a return to the normal wall
structure with complete tumor destruction (5.5 j). Histologic comparison among specimens also
121

correlates with these findings; a reduction in vasculature along with return to a semi-organized
mucosal structure is noted throughout the treated specimens.

5.3.3 Quantitative Analysis
In addition to the above qualitative comparisons, we extracted features from 23 non-overlapping
areas obtained from 12 untreated malignant tumors, 6 polyps, 3 post-treatment complete
responders or patients with no residual tumor following prior polypectomy, and 2 post-treatment
non-responders. We also extracted features from 18 normal non-overlapping areas from specimens
of normal regions. Thus a total of 41 non-overlapping regions were used. Note that each nonoverlapping area was obtained from each separate sample. These regions were identified by the
attending pathologist.
Figure 5.6 (a-g) shows the boxplots of the seven features calculated from the functional, spectral
and image differences between the different types of colorectal tissue. The n number given in the
plots corresponds to the total number of areas. The malignant regions demonstrated elevated
rHbT, 0.5MHz SI (PAT) and 0.5MHz SI (US) score smaller (less negative) compared to normal
and precancerous regions. For SS (PAT), the malignant regions score below normal and
precancerous polyps. Treated tumors with complete response were found to have similar scores to
normal tissue, while treated regions with residual cancer have scores similar to untreated cancers.
Due to the limited number of treated cancers, statistics were not performed for these two treated
categories.
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Figure 5.6: Boxplots of (a) total hemoglobin; (b) the mean spectral slope from PAT spectra; (c)
0.5 MHz spectral intercept from PAT spectra; (d) 0.5 MHz spectral intercept from US spectra; (e)
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energy from the second order statistics of PAT images; (f) homogeneity from the second order
statistics of PAT images; (g) standard deviation of the mean radon transform.

To distinguish untreated malignant from normal colon tissues, GLM and SVM classifiers were
established. These classifiers were developed using the independent features with a p-value less
than 0.05 between malignant and normal colon tissues. To determine if two features are
independent, Spearman’s correlation was calculated between each pair of features (Table 5.4). To
train each classifier, we first used the feature with the lowest p-value and then added other features
to the feature set one by one. We continued to include features to the feature set until no increase
in the AUC value for the testing data set was observed. We found that when rHbT was included in
the feature set, the best performance of both the GLM and SVM classifiers (the highest AUC value
for the testing data set) was achieved when rHbT and 0.5MHz SI (PAT) were employed to train
the classifier, although SS (PAT) has a lower p-value than 0.5MHz SI (PAT). Adding other
features did not improve the AUC for the testing data set.
Table 5.4: The correlation between significant features used in this study

rHbT
SS (PAT)

SS (PAT)

0.5MHz SI
(PAT)

0.5MHz
SI (US)

Homogeneity

Energy

Sig_rad

0.65

0.45

0.27

0.34

0.41

0.37

0.67

0.23

0.42

0.46

0.29

0.21

0.49

0.41

0.4

0.41

0.37

0.31

0.79

0.91

0.5MHz SI (PAT)
0.5MHz SI (US)
Homogeneity
Energy

0.82

Figure 5.7 shows the ROC curves and AUC values of the training (left) and testing (right) data sets
using GLM (top row) and SVM (bottom row) classifiers. As shown in this figure, when the features
set include just rHbT, the AUC values for the training and testing data sets are 0.95 and 0.93 for
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both classifiers, respectively. Adding 0.5MHz SI (PAT) to the features set results in a significant
improvement in the AUC values for both the training and testing data sets (0.97 and 0.95 for the
training and testing data sets for both classifiers, respectively). The three image features (Sig_rad,
Homogeneity, and Energy) did not improve the AUC values for either the training or testing data
sets.

Figure 5.7: ROC curves and their associated AUC values for the training and testing data sets in
the presence of rHbT in the feature set. (a), (b) GLM classifier performance. (c), (d) SVM classifier
performance.
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Figure 5.8: ROC curves and their associated AUC values for the training and testing data sets in
the absence of rHbT in the feature set. (a), (b) GLM classifier performance. (c), (d) SVM classifier
performance.

Finally, the performance of the GLM (top row) and SVM (bottom row) classifiers without rHbT
(the single-wavelength model) are presented in Figure 5.8. Note that although the difference
between some of the PAT image features in malignant and normal samples is statistically
significant, none of these features improve the AUC for the testing data sets. The best performance
of GLM classifier is achieved when the only spectral feature SS(PAT) is included in the feature
set. The best performance of SVM classifier is achieved when the spectral features SS(PAT),
0.5MHz SI(PAT), and 0.5 MHz SI(US) are included in the feature set. The testing AUC in this
case is 0.89 for the GLM classifier and 0.91 for the SVM classifier.
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5.4 Discussion and Summary
In this pilot study of co-registered ultrasound and photoacoustic tomography, we found significant
qualitative and quantitative differences between malignant tumors and normal tissue within human
colorectal specimens. Specifically, the parameters rHbT, 0.5MHz SI (PAT), 0.5MHz SI (US), and
SS (PAT) differ between the two tissue types imaged, suggesting that PAT may be able to
differentiate malignant from normal tissue in the colon and rectum. Combined with the PAT
system’s tissue penetration depth of over 4 to 5 cm (depending on the background tissue optical
properties), these findings suggest that PAT may be able to augment extant radiographic
technology in the diagnosis, management, and surveillance of colorectal cancer.
As demonstrated by Guan et al [27] and Ronald [28], PAT spectral features are related to the size
and concentration of the optical absorbers. The slope decreases (more negative) as PA absorber
sizes increase and the intercept increases (less negative) as the sizes and concentrations of the
absorbers increase. We believe that malignant lesions have larger absorber sizes and higher
concentrations compared with normal colorectal tissues due to their increased microvessel
networks. As introduced by Lizzi and co-workers [29], US spectral slope depends on acoustic
scatter size while spectral intercept depends on scatter sizes, concentrations and acoustic
impedances of tissue scatter matrix. These parameters have been found valuable to characterize
liver, eye [29], prostate [30], and breast lesions [31]. We believe that the distorted tissue
architecture and abundance of cancerous cells are the source of the US spectral contrast between
malignant and normal colorectal tissues. However, the findings of the PAT and US spectral
features of colorectal diseases may or may not be applicable to diseases of other organs.
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Several technical limitations must be considered with our data. First, we imaged colorectal
specimens obtained from routine surgeries and these tissues were typically with large pathologic
components that often appeared malignant by visual inspection after specimens were open. These
lesions may or may not need advanced PAT and US features for diagnosis. However, these lesions
are excellent examples for identifying PAT and US feature characteristics that differ between
cancerous and normal tissue. With this information known, we can target less obvious lesions as
we look to test the utility of the device in identifying cancer margins and residual tumors after
chemo-radiation treatment in patient.
The second limitation of this study is the low image resolution of our prototype. The image
resolution is only ~250 μm due to the commercial endo-cavity ultrasound transducer array (6 MHz
central frequency, 80% bandwidth). Because this resolution will impact future clinical applications
of the device, we plan to upgrade the ultrasound system with a transducer array of more than 15
MHz to address this problem in future studies. Third, hemoglobin oxygen saturation (sO2) was
not calculated in this study since all specimens were imaged after resection, resulting in
significantly altered oxygen saturation compared to normal living tissue. sO2 is a significant
biomarker for characterization of cancer [11] and assessment of treatment response.
Thirdly, the limited sample size could lead to overfitting of the classifiers if enough care is not
taken to develop the classifiers. As a rule of thumb, overfitting is least possible to occur if the
number of samples is 10 times or higher than the number of independent predictors [32]. Based on
this rule, as we have a total of 30 samples (18 normal colorectal tissues and 12 untreated malignant
colorectal tissues) for ROC analysis, the maximum number of the predictors that should be used
to avoid overfitting would be three. Figure 5.7 shows that when rHbT is present in the feature set,
the best performances of both GLM and SVM are achieved when rHbT and 0.5MHz SI (PAT) are
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the only features used to train the classifiers. Adding SS (PAT) to these feature set neither changes
the value of the AUC for training data sets, nor increases the AUC for the testing data set.
Moreover, when rHbT is not included in the feature set, employing the combination of SS (PAT),
0.5MHz SI (PAT), and 0.5MHz SI (US) features for developing the classifiers would result in the
best performance of SVM classifier and SS (PAT) only would result in the best performance of
GLM classifier (Figure 5.8). While adding Sig_rad increases the AUC value for the training data
set, it decreases the AUC values for the testing data set in both classifiers. This would mean that
our classifiers have most probably been overfitted when four features have been used. In this study,
to further protect our classifiers from overfitting, repeated rounds (100 times) of cross validation
were applied by randomly selecting 2/3 of the samples for training and 1/3 of the samples for
testing. The average ROC and AUC values were reported as the results.
In summary, a real-time co-registered PAT/US system was used to image and characterize
colorectal masses ex vivo in this pilot study. 23 colon and rectum samples (19 colon and 4 rectum)
were imaged, rHbT was computed from 4 wavelength data, and seven quantitative features were
extracted from PAT and US power spectra and images. In pre-treated malignant colorectal tumors,
we found the cross-section structure to be highly disorganized with a significantly higher rHbT
concentration compared to normal and precancerous regions. We performed classifications on the
malignant and normal colon regions using GLM and SVM classifiers both with and without tHb
in the feature set. When rHbT was employed to construct the classifiers with 0.5 MHz SI (PAT),
GLM and SVM classifiers achieved optimal AUC values for the training and testing data sets
(0.97 and 0.95, respectively). The small number of treated tumors included in this dataset limits
the statistical power of the analysis, but the functional, spectral and image parameters do appear
more similar to normal colorectal tissue in tumors that have experienced complete responses
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compared to partial responders. These results indicate potential of using PAT/US for future cancer
screening and post-treatment surveillance of the colon and rectum. Moving forward, we plan to
increase the resolution of our system by using a high frequency US array and then adapt the
technology to an endo-rectal probe, which will allow us to test the functional and spectral feature
differences in in vivo human tissue.

5.5 Develop a High-frequency Ultrasound Transducer
Array based PAT/US Imaging System to Improve Spatial
Resolution
5.5.1 Significance
Previously, we have performed a pilot assessment of human colorectal masses, using a coregistered PAT/US imaging system. These results indicate potential of using PAT/US for future
cancer screening and post-treatment surveillance of colon and rectum. The image resolution of the
current system is low (~ 250 μm axial resolution) due to the commercial endo-cavity ultrasound
transducer array (6 MHz central frequency, 80% bandwidth). To solve the problem of image
resolution, we decoded the pin configuration of a high-frequency transducer array (15 MHz central
frequency, 9-18 MHz bandwidth) and adapted it to our home-made 128 channels ultrasound
pulsing and receiving system (sampling rate: 40 MHz) to perform high frequency PAT/US
imaging. To futhter improve the performance of photoacoustic data acquisition suitable for highfrequency transducer array, we are building a 64-channel FPGA based high frequency
photoacoustic imaging system with a sampling rate of 80 MHz and signal-to-noise ratio (SNR) of

130

40 dB, and adapting this system to an endo-rectal probe with a side-firing fiber tip for in-vivo
patient study.

5.5.2 Approach
Figure 5.9 shows the setup of the high-frequency PAT/US system. A single Nd:YAG and
Ti:Sapphire 2-in-1 tunable laser was used to deliver pulsed laser light (Symphotic TII, LS-2145,
10 Hz repetition rate, 8-30 ns pulse duration, output fluence < 25 mJ/cm2 in the 700-800 nm
wavelength range). The single output light beam passed through a cylindrical lens array and was
split into four beams and finally coupled into four 1-mm core multi-mode fibers for tissue
illumination. A 3D-printed fiber holder was mounted to the high-frequency linear transducer array
(Fujifilm, VisualSonics MS-200, 15 MHz central frequency, 9-18 MHz bandwidth) with a darkfield scheme. One stepper motor was used to acquire several sequential B-Scans with a step size
of 2.5 mm. For each position, we mechanically tuned four wavelengths (730, 780, 800, 830 nm)
and recorded corresponding PAT/US images to calculate the relative total hemoglobin
concentration of regions of interest (ROIs). A home-made 128 channel US pulsing and receiving
system was used to acquire the images [33].
We also evaluated the spatial resolution of this high-frequency PAT/US imaging system, as shown
in Figure 5.10. The lateral and axial resolution were measured using a 250 μm black thread and
780 nm light. The black thread was placed perpendicular to the imaging plane at the zero degree
position and worked as a point source. The PAT signal coming from the black thread was measured
after the thread was put inside a water tank at ~ 2 cm depth. Then, the FWHM was calculated from
the fitted Gaussian curve after deconvolution with the transfer function of the transducer.
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As shown in Figure 5.10, we achieved a lateral resolution of ~ 150 μm and axial resolution of ~
120 μm. Also we imaged a post-treated human rectal tissue (non-responder, grade 3, 1.5 cm cancer,
more tumor at deep margin), as shown in Figure 5.11. From the pure ultrasound image, a clear
layer structure of the rectum wall in the normal area is observed, although we still cannot
differentiate the sublayers, such as the mucosa and submucosa, due to the low sampling rate of the
current US system (40 MHz sampling rate). From the PA image, there is a relatively dense
hemoglobin distribution within the rectum wall structure area. These findings appear correlated
with the histology exam. The H&E shows the ordered rectum wall layer structures in that location.
We are working on upgrading the ultrasound pulsing and receiving system with a higher sampling
rate (≥ 80 MHz).

Figure 5.9: Setup of high-frequency PAT/US imaging system.
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Figure 5.10: Spatial resolution evaluation.

Figure 5.11: Post-treated human rectum sample imaging (normal area).

For the FPGA based high frequency photoacoustic imaging system part (Figure 5.12), 8 ADC
boards (AFE5807EVM) and 2 FPGA control boards (Xilinx Artix 7) were employed. We used
another FPGA board (Intel Cyclone V) to generate an external 80 MHz clock to trigger the
sampling of the ADC boards. To move to an in-vivo patient study, a commercial endo-rectal probe
(BK Medical 8836) was sandwiched between two side firing fiber tips. To make the side firing
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fiber tip, we used a buffer wheel to polish the 1 mm core multi-mode fiber. We could adjust the
curvature of the concave surface to adjust the length of the side illumination area. We also designed
a 3D hand-held rotating platform combined with the rectal probe to perform volumetric PAT/US
imaging.

Figure 5.12: (a) Schematic diagram of FPGA based high-frequency photoacoustic imaging system;
(b) photograph of the system; (c) volumetric endo-rectal imaging probe with side-firing fiber tips.

Figure 5.13 also shows the LABVIEW based control software for the high-frequency
photoacoustic imaging system. We control probe rotation through LABVIEW interface for
Arduino toolkit and control the data acquisition from two FPGA boards to PC by controlling FTDI
USB chip inside the FPGA boards through FTD2XX.dll API. With this control software, we can
automatically rotate the probe to several positions and acquire the PA raw data from 64 channels
simultaneously for each position.
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Figure 5.13: LABVIEW based control software for the high-frequency photoacoustic imaging
system.
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Chapter 6: Photoacoustic laser effects in live
mouse blastocysts: pilot safety studies of
DNA damage from photoacoustic imaging
doses
6.1 Introduction
The photoacoustic effect – the conversion of light to sound – was first described by Bell in the late
1800’s [1]. With the advances of lasers, ultrasound transducers, and tomographic reconstruction
techniques, photoacoustic imaging (PAI) has become one of the fastest growing fields in
biomedical imaging [2, 3]. In PAI, nanosecond laser pulses are used as probing energy. The laser
induces photon absorption and thermoelastic expansion in the examined tissue, which results in
ultrasound waves. Thus, PAI reveals biological tissue optical contrast with ultrasound resolution.
Of significance, physiological parameters, such as relative total hemoglobin concentration and
oxygen saturation, could be defined with PAI.
The potential use of PAI on reproductive organs such as the ovary and uterus raises a question
about the effect of its exposure on embryos. The effects of a photoacoustic laser on preimplantation
embryos, to our knowledge, have not been reported. Previous studies have reported that intense
lasers can induce alterations in DNA, mitochondria, spindle apparatus as well as cell metabolism
and survival [4-8]. Yet, the laser parameters used in those studies differ significantly from the laser
parameters used in photoacoustic imaging systems. In addition, responses of cell lines to the laser
used in these studies are expected to differ from the responses of embryos. In order to establish a
stage-specific safety threshold of PAI on early embryos, studies need to be done with
photoacoustic laser parameters during specific stages of preimplantation embryo development
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such as the blastocyst stage. To the best of our knowledge, this study is the first to examine laserinduced DNA damage on pre-implantation mouse embryos using photoacoustic imaging lasers.

6.2 Methods
6.2.1 Mouse Embryo Sources
Frozen two-cell mouse embryos were purchased from Embryotech Laboratories. Embryos were
thawed according to the manufacturer’s protocol and subsequently cultured for 72 hours in vitro
in 50-μL drops of Continuous Single Culture-NX complete medium (Fujifilm Irvine Scientific)
under light mineral oil (Fujifilm Irvine Scientific). Embryos were group cultured at a maximum
density of 10 embryos per drop of medium in ASTEC IVF Cube low oxygen incubators (ASTEC
Co. Ltd.) at 37℃ and 6% CO2, 5% O2, and 89% N2. Our average mouse blastocyst formation rate
is approximately 89%. The study was exempted by the Institutional Animal Care and Use
Committee.

6.2.2 Laser Exposure
The embryos were suspended in 30 μL of medium in Eppendorf polymerase reaction (PCR) tubes
for laser exposure. The 5-minute 15-Hz and 10-minute 15-Hz laser doses represent the expected
doses in typical human reproductive tissue imaging studies. The 1-minute 1-kHz dose represents
a level of exposure that is significantly above that which may be used clinically. None of the
control blastocysts were exposed to the laser. Test samples were exposed to the laser at 780 nm
for 5 minutes or 10 minutes by delivering pulsed laser light through one 1.5-mm core multimode
optical fiber (FP1500ERT, 0.5 NA, Thorlabs) as shown in Figure 6.1. The light photons penetrate
through the Intralipid fat emulsion (Baxter) solution layer inside the three-dimensionally printed
water tank and the culture medium in the PCR tubes, and finally reach the embryos on the bottom
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of the tubes as shown in Figure 6.1. The 10-mm-thick calibrated Intralipid solution layer with an
absorption coefficient (μ𝑎 ) of 0.02 cm−1 and reduced scattering coefficient (μ′s ) of 4 cm−1 is used
to mimic a soft tissue layer between the probe and the embryos. One plastic film without optical
attenuation on the bottom of water tank is sandwiched by the Intralipid solution layer and the
culture medium layer with good contact on both sides. The laser used for illumination consists of
a Ti: Sapphire (LS-2134, Symphotics TII Corp.) optically pumped with a Q-switched Nd: YAG
laser (LS-2122, Symphotics TII Corp., 10-ns pulse duration, 15-Hz pulse repetition rate) [9,10].
The fiber tip output power is 0.55 mJ, which corresponds to the maximum permissible exposure
(MPE) (~ 28 mJ/cm2 at 780 nm) [11] based on simulations and measurements. The fluence level
delivered to the Intralipid solution layer surface was experimentally measured as follows: The
beam output from the fiber tip was Gaussian shaped and its diameter at the point where its peak
intensity drops to 1/e was measured using a variable iris diaphragm and energy meter which
corresponds to approximately 63.2% of the energy from the fiber tip. The beam area used for
calculating the fluence was measured to be the iris aperture that allowed 63.2% of the light energy
to pass through it, when the beam was centered on the iris [12]. Fluence equals the total input
energy divided by the circular area calculated by the detector radius. In experiments, the required
laser input energy reaching surface MPE (~ 28 mJ/cm2 at 780 nm) is 0.55mJ. We also used
another Nd:YAG laser with a much faster repetition rate (DPS-1064-Q, CNI Laser.com; 1064 nm,
1-kHz repetition rate, 7-ns pulse duration) . The fiber tip output power is 2 mJ, which corresponds
to the MPE (~ 100 mJ/cm2 at 1064 nm) [11] based on simulations and measurements.
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Figure 6.1: Light path from the fiber tip to the embryos. Embryos inside the polymerase chain
reaction tube were exposed to the 15-Hz laser at 780 nm for 5 minutes and 10 minutes, and 1-kHz
laser at 1064 nm for 1 minute by delivering pulsed laser light through one 1.5-mm optical fiber.

6.2.3 Staining Procedure
After the test groups were exposed to the laser, all groups of embryos were stained for imaging.
Embryos were suspended on negatively charged microscope slides within a hydrophobic PAP pen
circle. Embryo presence was verified using an Olympus SZX12 microscope (Olympus).
Medium was drawn off the slides, and the embryos were subsequently fixed in a 4%
paraformaldehyde (PFA) solution and incubated at room temperature in a humidified chamber for
25 minutes. The slides were stored in a -20C freezer overnight after fixation.
Slides were warmed and embryos were resuspended in 1xPBS. Embryos were incubated in a 1%
Triton solution for 25 minutes at room temperature in a humidified chamber to allow
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permeabilization of the cellular membranes. One slide was then treated with DNase and incubated
for 10 minutes at 37C in a humidified chamber to generate the positive control slide. The negative
control slide was not exposed to the laser, but underwent the same terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) staining protocol as the other groups.
A TUNEL assay kit was used to identify locations of DNA damage within the blastocysts. The
assay solution was prepared according to the manufacturer’s specifications. Slides were incubated
with TUNEL reagent in the dark for 1 hour in a 37C incubator in a humidified chamber. The
embryos were also incubated in a 4 M To-Pro-3-Iodide nuclear staining solution at room
temperature for 25 minutes in a humidified chamber.
After all staining procedures, excess liquid was removed and slides were sealed with a coverslip.
Slides were stored at -4C until imaging.

6.2.4 Blastocyst Microscopic Imaging
The mounted blastocysts were imaged by a confocal laser-scanning microscope (FV 1000,
Olympus). The embryos were first located using the 10X objective, and then the 60X objective
was used for imaging. The upper and lower bounds were found by adjusting the focus, and then
five slices were taken to ensure that all cells contained within the embryo could be counted. The
excitation wavelengths for TUNEL stain (TMR red) and To-Pro-3-Iodide are 589nm and 642nm,
respectively, and the lasers available for use had wavelengths of 543nm and 633nm. The emission
wavelengths of TMR red and To-Pro-3-Iodide are 615nm and 661nm, and the emissions were read
at 568nm and 633nm, respectively.
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6.2.5 Laser Damage Calculation
The cells with damaged DNA were then counted using the manual cell counter extension of ImageJ
software (National Institutes of Health), which allows for moving between slices while
maintaining one constant count and leaving tic marks to track previously counted cells. An
example of how the cells were counted in the positive control can be seen in Figure 6.2. The ToPro-3-iodide stain produced overexposed images, so the total number of cells could not be counted
from the nuclear stain.

Figure 6.2: A positive control embryo showing the counting tick marks provided by ImageJ
software.

6.2.6 Statistical Analysis
The mean and standard deviation of each of the five treatment groups were calculated based on
the number of damaged cells counted using ImageJ. Since some cells had weak nuclear stains,
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it was difficult to obtain the actual total cells to calculate the percentage of cell death, we
counted total number of damaged cells from each group. A two-tailed, independent t-test was
conducted to compare the total number of TUNEL positive nuclei in embryos that were or were
not exposed to the laser. A value of P < .05 was considered statistically significant.

6.3 Results
6.3.1 Embryo Microscopic Imaging
The images shown in Figure 6.3 are examples of all three groups examined using the confocal
microscope. Since the positive control embryos were treated with DNase, the cells within each
embryo were damaged and were visualized as strong red fluorescence under the microscope. The
gain on the TMR Red color of the TUNEL stain was left the same for all embryos in all trials, and
used to determine if embryos incurred any DNA damage. The nuclear stain gain was also left the
same between different embryos.
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Figure 6.3: Stained images of (A) positive control (DNase Treated), TUNEL stain only; B) positive
control, nuclear stain only; C) positive control, both stains; D) negative control (no laser exposure),
TUNEL stain only; E) negative control, nuclear stain only; F) negative control, both stains; G) 5minute 15-Hz laser-exposed, TUNEL stain only; H) 5-minute 15-Hz laser exposed, nuclear stain
only; I) 5-minute 15-Hz laser-exposed, both stains; J) 10-minute 15-Hz laser exposed, TUNEL
stain only; K) 10-minute 15-Hz laser exposed, nuclear stain only; L) 10-minute 15-Hz laser
exposed, both stains; M) 1-kHz laser-exposed, TUNEL stain only; N) 1-kHz laser-exposed,
nuclear stain only; O) 1-kHz laser-exposed, both stains.
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6.3.2 Quantitative Analysis of Effects of Different Laser Doses
Once the embryo images were acquired, they were imported into and processed using ImageJ. The
ImageJ manual cell counter was used to count the number of cells with DNA damage stained by
TUNEL, and those counts were used for the statistical analysis.
The negative control blastocyst group (no laser exposure) (n=10) had 10.7 +/- 6.56 (mean +/- SD)
TUNEL positive nuclei (Figure 6.4). The 5-minutes (n=16) and 10-minutes (n=9) 15-Hz laserexposed groups had 11.25 +/- 5.66 and 12.89 +/- 4.26 TUNEL positive nuclei. The embryos
exposed to the 1-kHz laser for 1 minute (n=14) had an average of 12.0 +/- 6.51 TUNEL-positive
nuclei (P=not significant for all comparisons).

Figure 6.4: Number of cells per embryo with damaged DNA in all embryo groups. N it the number
of embryos in each group.
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6.4 Discussion
The results provide a preliminary safety assessment of PAI on mouse embryonic cells. We
demonstrated that typical laser exposure times used for photoacoustic imaging do not induce
increased cell death in mouse blastocysts. Our study targeted blastocysts with a defined set of
laser parameters typically used in photoacoustic imaging clinical examinations. For example, in
our transvaginal photoacoustic imaging study of ovarian cancer [9], the 15-Hz Q-switched Nd:
YAG laser delivered laser energy transvaginally through optical fibers to illuminate ovarian tissue.
An ultrasound transducer detected the photoacoustic signals and mapped out lesion relative total
hemoglobin concentration and oxygen saturation. These measurements were successfully used to
differentiate normal/benign ovarian masses from invasive epithelial cancers. Using this method,
the laser fluence was controlled under MPE and the total scanning time to obtain the data was
typically about 5 to 10 minutes. The results reported in this article suggest that the laser energy
used and the scanning duration of 5 to 10 minutes are safe for a pregnancy during transvaginal PAI
evaluation.

In a rectal cancer study, the 1-kHz Nd:YAG laser delivered the laser energy

endoscopically via an optical fiber to illuminate the rectum. The imaging head, consisting of the
fiber and an ultrasound transducer, was used to screen for residual rectal cancer after neoadjuvant
treatment. Within a 1-minute period of time, 60 imaging frames was acquired safely.
PAI’s noninvasiveness, ease of integration with an ultrasound imaging system, and the potential
of functional imaging have resulted in increasing interest from physicians to incorporate it into
clinical practice. So far, human in vivo pilot studies using PAI have been mainly in the areas of
oncology [9, 13-21] and inflammatory diseases [22, 23]. The largest clinical trial thus far was a 3year prospective, multicenter study focused on breast cancer diagnosis. The study concluded that
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combined ultrasound and photoacoustic imaging helps radiologists assess breast masses with
increased specificity compared to gray scale ultrasound imaging alone [19].
To date, the use of PAI in the field of reproductive medicine has not been reported. The ability of
PAI to be coupled with an ultrasound system will provide complementary information, such as
vascular distribution and blood oxygen saturation, to the detailed imaging of the reproductive
organ structures. This additional information may prove beneficial during in vitro fertilization
(IVF) cycles. For example, during controlled ovarian stimulation, ultrasound is used to monitor
follicular development. Also, during the oocyte retrieval procedure, physicians use ultrasound
guidance to locate and to subsequently aspirate ovarian follicles. PAI, if incorporated, offers
information beyond the location, size and number of follicles such as the degree of follicular
vascularization. Studies have shown that follicles that appear similar in size and location can be
surrounded by a drastically different vascular environment [24]. The additional information can
be recorded and correlated with the developmental potential of eggs and thus serve as a potential
biomarker of egg quality. Furthermore, PAI could be used to measure the uterine endometrium
during IVF cycles, which might better define the optimal window of implantation of both fresh
and frozen embryo transfer cycles.
The use of PAI in clinical settings will result in exposure of reproductive organs to photoacoustic
laser rays. Current laser safety guidelines, however, are established based on ocular and skin
damage [11, 25, 26]. Photoacoustic lasers affect sensitive organs beyond the eyes and skin, as in
recent studies involving ovarian tissue [9]. To establish robust safety thresholds for PAI, studies
using photoacoustic laser parameters on specific biological targets are necessary. A typical
photoacoustic laser system consists of pulsed tunable near-infrared wavelength lasers with pulse
width (<10 nanoseconds), fluence (20-100 mJ/cm2 in the range of 700-1024 nm), and pulse
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repetition frequency (several Hz to a few kHz) to achieve high-quality real-time images of tissue
[27, 28]. In safety studies, tissues should be exposed to these laser parameters at time intervals
that reflect the duration of laser exposure in clinical settings. Post-laser exposure tissue
measurements such as cell death can help researchers and clinicians establish more informative
safety thresholds for PAI. These thresholds are critical for successful translation of PAI into
clinical use.
Although the pilot study gives a preliminary safety data of PAI on pre-implantation embryos,
experiments need to be performed to establish a dose-response curve of laser exposure on the rate
of cell death. For example, duration of exposure beyond 10 minutes for the 15-Hz laser needs to
be explored with a set of laser parameters typically used in clinical settings. Further experiments
are warranted to improve the experimental set up. For example, the embryos were centrifuged
onto the tube bottom before laser exposure. The distribution of embryos on the tube bottom,
however, are not well defined. Slightly non-uniformed embryo distribution will induce slightly
unequal laser fluence onto each individual embryo. A safety threshold on duration of exposure
could be established for this given set of laser parameters. Long-term embryo development, in
addition to cell death following the time of exposure, should be assessed.
In summary, our study reports the first evidence that the laser-induced DNA damage to mouse
embryos is negligible when the typical lasers used for photoacoustic imaging within a short
exposure time (15-Hz laser of 5 and 10 minutes, with 1-kHz laser of 1 minute representing a high
dose) are utilized. Further studies are warranted to establish a fuller safety profile for embryonic
tissues and reproductive organs for this novel imaging technology.
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Chapter 7: A fiber endface photoacoustic
generator for quantitative photoacoustic
tomography
7.1 Introduction
Ultrasound (US) generators have long been studied for use in biomedical ultrasound imaging [1],
focused ultrasound assisted drug delivery for treatment of tumors [2], and ultrasound nondestructive testing (NDT) [3].

However, the traditional piezo transducers are bulky, and

fabricating these transducers with millimeter-scale lateral dimensions is both challenging and
expensive.
Alternatively, optical ultrasound generators, especially fiber optic ultrasound generators, are
attractive candidates for many ultrasound applications [4-5]. The most common optical ultrasound
generation method exploits the PA effect [6], in which the generating material is excited by pulses
of laser energy that cause transient heating and localized temperature rises. The temperature rise
will cause contraction and expansion of the PA material due to thermal expansion effect. As a
result, the periodic compression and expansion will generate acoustic mechanical waves. The PA
waves’ emission intensity is proportional to the light fluence and the absorption coefficient of the
material. Due to the short pulse width of an ultra-fast laser, the pulse width of the generated
acoustic signals can be very short, and the corresponding frequency bandwidth of acoustic signals
can be broad.
Taking advantage of the submillimeter diameters of optical fibers and the PA effect, we developed a fiberbased PA wave generator (called a “PA generator” hereafter) that features a compact size and wide
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bandwidth. The system is useful for a variety of applications such as quantitative evaluation of biological
tissue absorption coefficients using photoacoustic imaging (PAI).
Accurately estimating functional parameters of biological tissue (e.g., total hemoglobin concentration and
oxygen saturation) using PAI is challenging because the detected signals are a convolution of product of
local fluence and tissue optical absorption with the system response. Computing the total hemoglobin
concentration depends on the accurate estimation of local absorption profile of the tissue which is coupled
with the local fluence. Nevertheless, by positioning the fiber endface of the calibrated PA generator close
to the target tissue and assuming identical local fluence for the generator and tissue, we can assume that the
mean PA signal ratio of the target tissue and the generator can approximate the ratio of their absorption
coefficients provided that the absorption coefficients of PA generator and target tissue are linearly related.
As a result, the absorption coefficient profile of the target tissue can be estimated by using the fiber endface
PA generator as a reference. Such PA generators can be used with biopsy needles or surgical implantable
devices for quantitative PAI. Additionally, these generators can also be imbedded inside the brain as
broadband acoustic sources to activate neurons.
The PA wave generation material is an important factor. Recently, various studies have described
developing and applying novel materials to improve PA wave generation efficiency. Several papers have
reported that polymer-based materials show higher PA generation efficiency than metallic materials [7-8].
For instance, Biagi et al. demonstrated that, compared to metallic materials, graphite powder mixed with
epoxy resin could increase the conversion efficiency by two orders of magnitude [9]. Zou et al. synthesized
a gold nanocomposite by directly mixing gold nanoparticles with polydimethylsiloxane (PDMS), then
coated it on the optical fiber tip for PA emission [10]. Baac et al. used a nano-composite film of carbon
nanotubes (CNTs) and elastomeric polymer as an efficient PA source [8, 11]. Shi et al. combined multiwall carbon nanotubes (MWCNTs) and PDMS to achieve a high light absorption coefficient and high
157

thermal expansion coefficient [12]. However, all of these PA generation materials involve complicated
designs and demanding fabrication protocols. Moreover, they all lack a high optical absorption within 700900 nm. Materials in reference [12] were designed for narrowband and sub-MHz frequency emission which
are not suitable for most biomedical applications. Materials in reference [8, 11] required growing a multilayer carbon nanotube on a fused silica substrate which is difficult to control its quality and extremely
expensive. Also, PDMS based curing agent makes the manufacturing process time-consuming and
difficult for controlling the fiber tip generator dimension precisely [7-12].
In this work, we report a fiber endface PA generator with a wide acoustic bandwidth, high thermal
conversion efficiency, good PA singal controllability, and high feasibility (simple procedures). This novel
generator could be a useful tool for calibrating the local absorption coefficient of biological tissue for
quantitative PAI.

7.2 Methods and Materials
The fiber endface PA generator, as illustrated in Figure 7.1 (a) and Figure 7.1 (b), was fabricated by
applying IR 144 dye (Exciton, Lockbourne, OH, USA) on the fiber tip. A piece of multimode fiber
(FP1000ERT, 0.50 NA, THORLABS) with a core diameter of 1000 μm was stripped and cleaved, and the
end face was polished. Then it was dipped into a mixture of IR 144 and UV adhesive (Norland Optical
Adhesive 63, EDMUND OPTICS) and gradually pulled out to form a partial spherical tip due to the high
viscosity and surface tension of the adhesive [13]. The tip ws exposed to UV light for several seconds for
fast curing, then it was placed under a microscope for inspection. Any tip with a non-spherical shape was
re-fabricated again. After the tip passes the inspection, it went through a UV exposure of several minutes
to fully cure the UV adhesive.
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IR 144 is a tricarbocyanine dye widely used in various biomedical applications employing near-infrared
(NIR) imaging due to its high absorption cross-section at around 750 nm and strong fluorescent emission
in the NIR regions. However, NIR-emitting dyes often have relatively low quantum yields (commonly in
the range of 2-10% [14]) compared to the yields of traditional red-emitting fluorescent dyes (up to 96%
[15]). The reported quantum yield value of IR 144 in DMSO is 5% [16], and the rest of the absorbed energy
could lead to high thermal and thus PA conversion efficiency. Additionally, due to the presence of long
extended conjugation in the chemical structure, IR 144 shows a high light energy conversion rate [17]. To
our best knowledge, this is the first time that IR 144 has been used for PA wave generation.
We acquired the PA emission signals from the fiber endface photoacoustic generator and 200-μm
diameter carbon fiber (approximated as a point source) using our previously described coregistered PAI/US imaging system [18]. The detected PA signals for each target were processed
with FFT and the spectra are shown as a function of frequency (Figure 7.1 (c)). To briefly describe
the PAI/US system, a Ti: Sapphire laser (Symphotics TII, LS-2122) optically pumped with a Qswitched Nd: YAG laser (Symphotics TII, LS-2134) was employed to deliver pulsed laser light
(10-30 ns pulse duration, 15 Hz pulse repletion rate). For data acquisition, a commercial ultrasound
system (EC-12R, Alpinion Medical Systems) and a linear ultrasound transducer (L3-12H, center
frequency of 8.8 MHz and -6dB ultrasound bandwidth ≥60%) were used.
As shown in Figure 7.1 (c), the PA generator spectrum (brown color) in 2 to 7 MHz range closely
follows the carbon fiber spectrum (blue) indicating a broad PA signal bandwidth of the IR 144 dye.
The -30dB width of the PA generator and the 200-μm carbon fiber is 2.1-6.6 MHz and 2.2-6.8MHz,
respectively.
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Figure 7.1: (a) Microphotograph of the fiber endface PA generator; (b) Schematic of the generator;
(c) The frequency response of the PA generator and 200-μm diameter carbon fiber.

7.3 Results
The absorbance was calculated by log10 (I0 /I), where 𝐼0 and 𝐼 are the intensity of incident and
transmitted light, respectively. By measuring absorbance at different wavelength, the absorption
spectrum of IR 144 was obtained with a Beckman DU-640 spectrophotometer (Beckman Coulter,
Inc., Indianapolis, IN, USA). A stock solution of IR 144 was prepared in DMSO (1 mg/ml) from
which IR 144 samples with different concentrations were diluted. The samples were placed in
quartz cuvettes, and their UV-Vis absorption spectra were recorded.
Figure 7.2 (a) shows absorbance versus wavelength plots for IR 144 concentrations from 0.3125
to 20 μg/ml. The peak absorbance occurs at around 745 nm. Also, the plots suggest that absorbance
increases with IR144 concentration. Figure 7.2 (b) shows the peak absorbance value occurring at
745 nm as a function of IR 144 concentrations. The linear relationship of the peak absorbance and
the IR144 concentrations indicates an R2 of 0.9963. We also calculated the mean PA signal from
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the recorded PA generator signals. We selected an appropriate region of interest (ROI) based on
the ultrasound image and calculated the mean value of the PAT image envelopes within the ROI.
Then we normalized the mean value to the corresponding fiber tip power measured by a power
meter to obtain the normalized mean PA signal at each wavelength. Figure 7.2 (c) shows the
normalized mean PA signal and the corresponding absorbance for wavelengths from 730 to 850
nm. The plots of the PA signal and absorbance follow similar trends, which are in accord with the
PA principle that the profile of the acoustic signals is similar to the profile of the absorption
coefficient for a constant fluence.
Figure 7.3 (a) shows the experimental setup for validating the calibration accuracy of the fiber
endface PA generator. Three generators with three concentrations were buried with equal lateral
distance inside a calibrated phantom (made of intralpid and gelatin, absorption coefficient μa, 0.02
cm-1; reduced scattering coefficient μs’, 4 cm-1) at a depth of 20 mm. Guided by co-registered US
images, the three generators were oriented perpendicular to the transducer imaging plane.
However, small angles might occur and the PA signal variation was less than 3% which would not
affect the results. Figure 7.3 (b) and Figure 7.3 (c) show the corresponding 1-D profiles across the
three fiber endface PA generators for two sets of concentrations (2.5, 5, and 10 μg/ml; and 1.25,
2.5, and 5 μg/ml) acquired from the PA images at 745 nm. Based on the linear relationship of IR
144’s absorbance and concentration at 745 nm (Figure 7.2 (b)), the true PA signal ratio of the
generators with adjacent higher to lower IR 144 concentrations is around 2, which is consistent
with the experimental ratios: 1.74 and 1.78 marked in Figure 7.3 (b), and 2.27 and 1.87 in Figure
7.3(c).
Figure 7.4 (a) shows the experimental setup of the PA generator calibration with either of two targets:
cypate (Optical Radiology Lab, Washington University in St. Louis) and IR 140 (Exciton, Lockbourne,
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OH, USA). Just as in Figure 7.3 (a), one fiber endface generator and one target were buried inside the
calibrated phantom perpendicular to the transducer imaging plane at a depth of 20 mm.
The laser wavelength was 745 nm, and the IR 144 concentration was 2.5 μg/ml. Cypate and IR 140 are
two frequently used NIR dyes with absorbance in the 700-900 nm range. The measured absorbance of the
cypate and IR 140 samples at 745 nm were 0.92 and 0.97. Based on the results in Figure 7.2 (a), the
measured absorbance of the fiber endface PA generator (2.5 μg/ml) at 745 nm was 0.39. As a result, the
true PA signal ratios of cypate and IR 140 to the signal of the generator were 2.49 and 2.36, which match
well with the experimental ratios: 2.34 in Figure 7.4 (b) and 2.18 in Figure 7.4 (c).
Figure 7.5 (a) shows the experimental setup of the fiber endface PA generator calibration of a mouse blood
sample. The mouse blood samples were collected from a C57BL/KaLwRij mouse (10 weeks old) via
cardiac puncture under deep anesthesia and transferred into EDTA tubes to prevent blood coagulation. The
blood samples were diluted with saline water to achieve different absorbances. Then it was injected into a
5 mm diameter tube which was then tightly capped. The fiber generator and blood tube were submerged
inside a tank filled with 0.4% calibrated intralipid solution (Fresenius Kabi, USA) perpendicular to the
transducer imaging plane at a depth of 20 mm. The intralipid solution had a μa of 0.02 cm-1 and μs’ of 4
cm-1. The laser wavelength used here was 745 nm and the IR 144 concentration was 2.5 μg/ml. As shown
in Figure 7.5 (b), strong PA signals (yellow) were detected from the generator and blood tube area (gray).
Meanwhile, second reflection PA artifacts were observed underneath the blood PA signals at a depth
roughly two times that of the blood PA signals due to transducer face absorption. The measured absorbance
of the fiber endface PA generator (2.5 μg/ml) and blood sample (diluted 20 times) at 745 nm were 0.39 and
2.04.
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As a result, the true ratio of the PA signals of the blood sample and the generator was 5.22, which agrees
well with the experimental ratio in Figure 7.5 (c). Figure 7.5 (d) shows the mean PA signal value of
the blood sample at 745 nm as a function of the measured blood sample absorbance (1.09, 1.67,
2.1, 2.59) with respect to different dilution rates (~ 30, 25, 20, 15 times). The linear relationship
of the mean PA signal and the blood sample absorbance indicates an R2 of 0.98. We also compared
the experimental blood sample absorption coefficients with respect to different dilution rate and
the measured ones and there showed a good match with a difference less than 0.5 cm -1 in Figure
7.5 (e).
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Figure 7.2: (a) Absorbance plots of IR 144 as a function of wavelength for concentrations from
0.3125 to 20 μg/ml (solvent: DMSO); (b) The peak absorbance value at 745 nm as a function of
IR144 concentrations; (c) The normalized mean PA intensity and the corresponding absorbance as
a function of wavelength.
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Figure 7.3: (a) Experimental setup to validate the calibration accuracy of the fiber endface PA
generator (the light was delivered through the fiber itself to its endface); (b) and (c) Corresponding
1-D profiles across three different fiber endface PA generators (averaged from 10 consecutive
envelopes along the depth) with respect to two sets of IR 144 concentrations (2.5, 5, and 10 μg/ml;
and 1.25, 2.5, and 5 μg/ml). The PA intensity ratios of the generators with higher to lower IR 144
concentrations are also provided in each profile.
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Figure 7.4: (a) Experimental setup of the PA generator target calibration (the light was delivered
through the fiber itself to its endface); (b) and (c) Corresponding 1-D profiles (averaged from 10
consecutive envelopes along the depth) across one PA generator (left, IR 144 with a concentration
of 2.5 μg/ml) and one target (right, cypate and IR 140). The ratios of the PA intensity of the target
to that of the generator are also provided in each profile.
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Figure 7.5: (a) Experimental setup of the fiber endface PA generator calibration of a mouse blood
sample (the light was delivered from the top of the water tank perpendicular to the intralipid
solution); (b) Co-registered PA/US images of the generator and mouse blood sample (dynamic
range: 18 dB, colorbar refers to normalized PA signal); (c) The corresponding 1-D profile
(averaged over 2 mm in depth) across one fiber endface generator (left, IR 144 with a concentration
of 2.5 μg/ml) and one mouse blood sample (right, injected into a 5 mm diameter tube). The PA
intensity ratio of the blood sample’s intensity to the generator’s intensity is also provided; (d) The
mean PA intensity value of the blood sample at 745 nm as a function of the measured blood sample
absorbances with respect to different dilution rates; (e) The comparison between the experimental
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absorption coefficient of the blood sample based on the mean PA signal ratio and the measured
absorption coefficient based on the spectrophotometer measurement (concentration 1-4 refer to 4
dilution rates of the blood sample).

7.4 Discussion and Summary
In this paper, we have demonstrated a novel fiber endface PA generator, made of a mixture of IR 144 and
UV adhesive. IR 144 has been widely used in various biomedical applications with signals in the NIR range.
With a high absorption cross-section and low quantum yield (5%), it achieved a high thermal conversion
efficiency (>90%) and thus high PA conversion efficiency. The PA emission frequency exhibited a
broad bandwidth as the point-like carbon fiber. The IR 144 absorbance at 745 nm was linearly
correlated with its concentration with an R2 of 0.9963. By experimentally validating the generator’s
calibration accuracy with different concentrations and different target materials, we demonstrated
good consistency between the experimental and calibration results. Finally, we used the generator
to calibrate the absorption coefficient of a mouse blood sample, mimicking biological tissue. Again,
there was a good match between the experimental and calibration results with a difference less
than 0.5 cm-1.
In summary, we have introduced a novel fiber endface PA generator using IR 144 dye which can
be a broadly useful tool in biomedical applications. We have demonstrated experimentally that the
generated PA signal has a broadband width in the frequency range of 2-7 MHz evaluated and linearly
increases with the dye concentration up to 20 μg/ml. The generator can be used as a reference to calibrate
local absorption of the tissue. Additionally, IR 144 dye is commercially available which can facilitate
clinical translation of such fiber-based acoustic generators.
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Moreover, dual modality fluorescent and

photoacoustic imaging can be achieved by utilizing IR 144’s moderate quantum yield in NIR region and
the good PA conversion efficiency.
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Chapter 8: Summary and Future Work
8.1 Summary
This dissertation is focused on exploring co-registered photoacoustic and ultrasound tomographic
imaging on two fatal cancers: ovarian cancer and colorectal cancer. It is composed of three main
parts: light delivery optimization/fiber optics, system development and optimization, and pilot
patient and sample study. First project described in chapter two is related to the light delivery
optimization/fiber optics part. We designed and evaluated an optimized hand-held photoacoustic
and ultrasound probe suitable for endo-cavity tumor subsurface imaging. Compared to previous
designs, the prototype probe, consisting of four 1 mm multi-mode optical fibers attached with 1.5
mm diameter ball-shaped fiber tips sandwiched between a transvaginal ultrasound transducer and
a custom-made sheath, demonstrated a higher light output and better beam homogeneity on tissue
subsurface. The simulations and experiments demonstrated that ball-shaped fiber tip design can
achieve homogeneous fluence distribution on tissue subsurface with acceptable light output
efficiency, suggesting its clinical potential for in-vivo endo-cavity imaging. Based on the ball lens
design, we made an improved version of design in chapter three in which we developed an
effective fiber diffuser tip to reduce the fluence on the target tissue surface while injecting more
laser energy and enhancing the photoacoustic signal generated from the tissue. The fiber diffuser
tip is made of silica microspheres mixed with UV adhesive. We compared the light diffusion
effects of different microsphere materials, sizes, and concentrations, and find 10 μm silica
microspheres provide the best light scattering with minimal 5% output energy loss. With Zemax
simulation and experimental validation, we show this fiber diffuser tip could be a valuable tool for
endo-cavity photoacoustic imaging.
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In chapter four, we proposed an improved beamformer named lag-based delay multiply and sum
combined with coherence factor (DMAS-LAG-CF). Simulations and phantom experiments
demonstrate that compared with the conventional DAS, the proposed algorithm can provide 1.39
times better resolution and 10.77 dB higher contrast. With a cohort of 28 patient data, similar
performance on contrast ratios have been observed. However, since the diagnostic accuracy
between cancer and benign/normal groups is the significant measure, we have extracted
photoacoustic histogram features of mean, kurtosis and skewness. DMAS-LAG-CF can improve
cancer diagnosis with an AUC of 0.91 for distinguishing malignant vs. benign ovarian lesions
when mean and skewness are used as features.
Continuing the pilot clinical patient/sample study, we have conducted a pilot study on 23 ex-vivo
human colorectal tissue samples immediately after the surgical resection to investigate the ability
of co-registered photoacoustic and ultrasound tomographic imaging to assess human colorectal
cancer in chapter five. Co-registered photoacoustic images of malignancies showed significantly
increased PAT signal compared to normal regions of the same sample. The quantitative relative
total hemoglobin concentration (rHbT) computed from four optical wavelengths, the spectral
features, such as the mean spectral slope, and 0.5 MHz intercept extracted from PAT and US
spectral data, and image features, such as the first and second order statistics along with the
standard deviation of the mean radon transform of PAT images, have shown statistical significance
between untreated colorectal tumors and the normal tissue. Using either a logistic regression model
or a support vector machine, the best set of parameters of rHbT and PAT intercept has achieved
AUC values of 0.97 and 0.95 for both training and testing data sets respectively for prediction of
histologically confirmed invasive carcinoma.
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One limitation of the current system is the poor image resolution (~ 250 μm axial resolution) due
to the commercial endo-cavity ultrasound transducer array (6 MHz central frequency, 80%
bandwidth). To solve the problem of image resolution, we firstly decoded the pin configuration of
a high-frequency transducer array (15 MHz central frequency, 9-18 MHz bandwidth) and adapted
it to our home-made 128 channels ultrasound pulsing and receiving system (sampling rate: 40
MHz) to perform high frequency PAT/US imaging. To further improve the performance of
photoacoustic data acquisition suitable for high-frequency transducer array, we are building a 64channel FPGA based high frequency photoacoustic imaging system with a sampling rate of 80
MHz and signal-to-noise ratio (SNR) of 40 dB, and adapting this system to an endo-rectal probe
with a side-firing fiber tip for in-vivo patient study.
In chapter six, since we did a lot clinical applications on human ovarian cancer and colorectal
cancer, we'd like to investigate the laser safety of photoacoustic imaging especially before its
adoption by clinical reproductive medicine. Potential DNA damage of photoacoustic laser
exposure on preimplantation mouse blastocyst stage embryos was examined. Different embryos
groups were exposed to either 5- or 10- minute 15-Hz laser doses (typical clinical doses), and 1minute 1-kHz laser dose (significantly higher dose), respectively. We demonstrated that typical
lasers and exposure times used for photoacoustic imaging do not induce increased cell death in
mouse blastocysts.
In chapter seven, we presented a novel fiber endface photoacoustic generator using IR 144
dispersed within an UV adhesive. The generator provides wide acoustic bandwidth in the
transducer frequency range of 2-7MHz, high thermal conversion efficiency (> 90%), good PA
intensity controllability (well controlled IR 144 concentration), and high feasibility (simple
procedures). Through a series of experimental validations, we show this fiber endface photoacoustic
174

generator can be a useful tool for a broad range of biomedical applications, such as calibrating the local
absorption coefficient of biological tissue towards quantitative photoacoustic tomography.

8.2 Future Work
8.2.1 Transmission-mode Ultrasound Imaging Using the Fiber Endface
Photoacoustic Generator
To demonstrate the capability of the fiber endface photoacoustic generator to image tumor
morphology, we performed a simple model experiment, as shown in Figure 8.1(a). We used a
motorized stage to move the fiber tip acoustic generator to several positions and recorded the
acoustic signal with a linear transducer array. We put a soft plastic tube between the acoustic
generator and linear transducer array to mimic a tumor. By calculating the acoustic attenuation
induced by the tube from several different angles, we could reconstruct the tumor shape as shown
in Figure 8.1(b). If we progress to consider real biological tissues, we can coat materials with different
absorption peaks on different tips so that we can tune the laser light wavelength to control the acoustic
emission at different positions, instead of mechanically changing the fiber tip position.
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Figure 8.1: (a) Schematic of fiber endface photoacoustic generator for transmission-mode
ultrasound imaging of the tumor mimicking soft tube. (b) The Reconstruction result of the soft
tube.

8.2.2 Photoacoustic Remote-sensing Imaging of Human Ovarian and Colorectal
Cancer
Photoacoustic methods have demonstrated great success in many applications. However, for many
clinical applications, such as wound healing, burn diagnostics, surgery and many endoscopic
procedures, physical contact, coupling, or immersion is undesirable or impractical. Optical
methods to detect ultrasound and photoacoustic signals have been investigated over a number of
years. Very recently, Hajireza et al. proposed a non-interferometric photoacoustic remote sensing
microscopy (PARS) which intentionally eliminated phase-sensitivity to exclusively monitor
intensity reflectivity changes [1]. This work introduces a new mechanism and methodology to
detect photoacoustic signals at the subsurface origin, where pressures are maximal. Elasto-optical
refractive index changes due to photoacoustic initial pressure transients are shown to produce a
significant time-varying reflection of a probe beam. Lots of applications have been demonstrated
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using PARS especially on digital histology [2-3]. Also they combined PARS with optical
coherence tomography (OCT) for better cancer diagnosis [4-5]. I believe PARS could be a very
powerful tool for ovarian cancer and colorectal cancer diagnosis.

Figure 8.2: Experimental setup of photoacoustic remote-sensing microscopy (PARS) with 532-nm
excitation and 1310-nm integration beams (from Ref. [1]).
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